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The interest in the diagnostic potential of volatile organic compounds
(VOCs) in breath increases as a result of constantly improving modern an-
alyzing techniques. Unfortunately, physicians have paid little attention to
a causal mathematical description of the underlying physiological processes
yet. Even if mathematical models are idealized representations of the re-
ality, their impact on combining all the information and in prediction is
undisputable.
The emphasis of this work was to derive a mechanical description of the
physiological processes governing the gas exchange dynamics of isoprene un-
der physical exercise. Isoprene has been classified in the group of biomarkers
and can be seen as a prototypic example of low-soluble substances concern-
ing its gas exchange mechanisms. Modern mass spectrometric techniques
allow its online quantification in exhaled breath in real time.
Describing short-term effects is crucial to get a deeper understanding of
the determining factors of the underlying mechanisms. Changes in physi-
ology occurring during physical exercise, such as increased ventilation and
increased cardiac output, offer an opportunity to examine and understand
the exchange processes that determine absorption, desorption, and distri-
bution of this important volatile organic compound. Thus, for the present
work cycling exercises on a medical ergometer were carried out and an ex-
perimental setup allowing parallel and real-time measurements of exhaled
isoprene time-courses in conjunction with physiological parameters was used
to collect relevant information for modeling purposes.
Isoprene concentrations show a distinct peak shaped response to exer-
cise, which has been recognized before by several investigators. The existing
model describing exhaled dynamics of isoprene in response to exercise is able
to explain its dynamics only on the basis of physiological assumptions, which
contradict physiological facts and real-time measurements. As conventional
knowledge suggests isoprene is expected to be sensitive to the regional in-
homogeneities in the lung due to its low solubility in blood. For this reason,
we focused our attention onto various existing lung models first, which take
into account regional inhomogeneities of the lung. However, such representa-
tions also fail to describe the observed data. On the contrary, experimental
evidence suggests a relationship between muscle compartment activity and
isoprene excretion. The first known physiological model developed for iso-
prene exposure studies assumes a production of isoprene in the liver as the
solely source of isoprene in the human body and fails to describe its ex-
change dynamics under physical exercise. Based on this model, we derived
a compartment model, which suggests a metabolic activity of the skeletal
muscles. The new model is capable to explain the observed isoprene profiles
within a range of acceptable parameter sets.
Even if further investigations are necessary to consolidate this hypothe-
sis, several findings about isoprene, such as the linkage of its output to age
and statin therapy, and the effect of bilateral deficit when switching from
two-legged to one-legged exercise appear to fit into this hypothesis.
Chapter 1 of this thesis briefly summarizes the motivation behind the
breath gas analytical investigations, experimental setup used for the exper-
iments, and classical theory of pulmonary gas exchange.
Chapter 2 concerns the derivation of compartmental mass balance equa-
tions used in physiological modeling.
Chapter 3 covers the description of mathematical and numerical meth-
ods for qualitative and quantitative analysis of modeling and parameter
estimation processes.
The first 5 sections of chapter 4 represent existing modeling approaches
and discuss their physiological relevance. Subsequently, some insightful ex-
periments are presented which lead to the new model developed by our
research group. This model has been refined and a more specific location of
isoprene, namely skeletal muscles is suggested.
The appendices summarize fundamental physical principles underlying
the derivation of physiologically based models and parameter values.
Zusammenfassung
Der menschliche Atemluft entha¨lt hunderte von flu¨chtigen Spurenele-
menten, die entweder im Organismus als Folge von biochemischen und meta-
bolischen Prozessen entstehen, oder von der Umwelt absorbiert werden.
Der Quantifizierung von flu¨chtigen organischen Spurenelementen (VOCs) im
menschlichen Atem wird ein diagnostisches Potential zugeschrieben. Atem-
gasanalyse ist die wissenschaftliche Untersuchung der Atemluft und ihre
Hauptmotivation ist die Suche nach Marker-Substanzen, die als Indikatoren
von pathophysiologischen Erkrankungen dienen ko¨nnen.
Aufgrund ihrer nicht-invasiven Natur haben atemgasanalytische Unter-
suchungen in den letzten Jahren enorm an Interesse gewonnen. Allerdings ist
der nicht-invasive Test noch in Entwicklung und hat in der klinischen Rou-
tine noch nicht Eingang gefunden. Neben Problemen bezu¨glich der Standar-
disierung der Atemluftabnahme und der Analysemethoden, verhindert das
unzureichende Wissen u¨ber die Herkunft und die biochemischen Prozesse
dieser Substanzen die Anwendung der Atemtests.
Die physiologisch basierte mathematische Modellierung spielt bei der
quantitativen Analyse der experimentellen Daten eine entscheidende Rolle.
Ihre Aufgabe ist es, eine mechanische Beschreibung der zugrundeliegenden
physiologischen Pha¨nomene unter Beru¨cksichtigung aller relevanten exper-
imentellen Daten zu liefern. Somit ermo¨glicht die mathematische Model-
lierung einerseits ein detailliertes Versta¨ndnis der physiologischen Vorga¨nge
und kann andererseits aufgrund dessen bei der Standardisierung und En-
twicklung der Atemluftentnahmemethoden eine wichtige Rolle spielen. Die
Arbeit konzentriert sich auf Isopren, welches eine der wichtigsten organis-
chen Substanzen in der menschlichen Atemluft ist. Das Ziel der vorliegen-
den Arbeit war, den quantitativen Zusammenhang zwischen den Atem-
luftkonzentration und der zugrundeliegenden endogenen Blut/und Gewe-
bekonzentrationen von Isopren zu beschreiben. Um die Kurzzeiteffekte der
relevanten physiologischen Faktoren (sowie Blutfluss und Atemfluss) zu bes-
timmen, wurden Echtzeitmessungen unter Ergometerbelastung durchgefu¨hrt.
Die herko¨mmlichen Modelle, die sich hauptsa¨chlich auf die funktionellen
A¨nderungen der Lunge konzentrieren, sind nicht in der Lage, eine phys-
iologisch relevante Beschreibung der experimentellen Daten zu liefern. Im
Gegensatz dazu wurde ein neues Modell auf Basis einer peripheren Herkunft
von Isopren von unserer Arbeitsgruppe entwickelt. Die neue Hypothese
wurde in der vorliegenden Arbeit durch weitere Experimente bekra¨ftigt und
das zugrundeliegende Modell verfeinert, was uns zu der Schlussfolgerung
fu¨hrte, dass die Skelettmuskeln eine wichtige Rolle bei der Isoprenformation
spielen.
Diese Hypothese wirft ein neues Licht auf die bisherigen Untersuchungen
und ero¨ffnet neue Diskussions- und Interpretationsmo¨glichkeiten u¨ber die
Herkunft von Isopren.
Keywords: Breath gas analysis, isoprene, volatile organic compounds, mod-
eling
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Chapter 1
Introduction
1.1 Breath Gas Analysis and The Need for Mod-
eling
The linkage of human breath composition to health and disease has been
noticed long since. Our current day understanding of the diagnostic po-
tential of breath gas can be traced back to antiquity as demonstrated by
Hippocrates in his treatise on breath aroma and disease [26].
In 1784 Lavoisier and Laplace showed that respiration consumes oxygen
and eliminates carbon dioxide. In the mid 1880s Nebelsthau discovered the
relation between breath acetone and diabetics, and in 1874 Anstie isolated
ethanol from breath, which is the basis of breath alcohol testing today [26,
69]. However, a major breakthrough in the scientific study of breath started
in the 1970s when Linus Pauling demonstrated the existence of more than
250 unique substances in exhaled breath [84]. Since then, breath gas analysis
has rapidly evolved as a new diagnostic tool in medical testing for respiratory
and systemic diseases.
Besides oxygen and carbon dioxide, human breath contains elemental
gases like nitric oxide, carbon monoxide, and a multitude of volatile organic
substances. The small inorganic molecule nitric oxide (NO) is predomi-
nantly generated in the bronchial system and is subject to several medical
investigations since it has been recognized as a mediator of numerous phys-
iological processes and as a marker of airway inflammation. The significant
role of NO in vasodilation of blood vessels has been proved in the Nobel
prize-winning work by Furchgott, Ignarro and Murad, which nowadays has
reached clinical applications [14, 57]. Volatile organic compounds (VOCs)
are a large group of carbon-based (hence organic) chemicals which include
a very wide range of individual substances, such as aldehydes, halocarbons,
oxygenates, ketones, and hydrocarbons. Volatility indicates that the gases
mentioned have high vapor pressure under normal conditions (at room tem-
perature), and thus can significantly vaporize and enter the exhaled air.
3
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The initial technical difficulties in detection and identification of VOCs in
exhaled breath have been for the most part overcome due to the development
of very sensitive modern analyzing-techniques (such as mass spectrometry
(MS), gas chromatography (GC) and gas spectrometry mass spectrometry
(GC-MS)) in the last three decades. Now more than 200 VOCs can be
detected at trace level down to the parts-per-trillion (ppt) range in human
breath [4, 12,39,60,64,84,85].
For VOCs, sampling and analysis of breath is preferred to direct mea-
surement from blood samples, because breath collection is non-invasive and
can be carried out as often as desirable. This has led to an increased interest
of the physiological meaning of VOCs and correlations of their concentra-
tions with patients’ clinical conditions.
While exogenous VOCs are absorbed from the environment by inhala-
tion, ingestion or skin contact and thus are of interest for quantifying the
body burden in response to environmental exposure [7, 86], endogenous
VOCs originate from biochemical and metabolic processes in the human
body. It is believed that the concentration of blood-borne VOCs in exhaled
breath is a reflection of their concentration in blood through gas exchange in
the blood/breath interface in the lungs (due to their volatility, the kinetics of
VOCs can be approximated according the substance solubilities), therefore
some systemic diseases accompanied by metabolic and oxidative stress al-
ter the pattern of exhaled VOCs concentrations [73]. Among others, breast
cancer, diabetes mellitus, lipid preoxidation, heart, liver and renal diseases
have been investigated in association with exhaled VOC profiles. Table 1.1
provides a selected list of VOCs and related disorders and/or clinical appli-
cations. References and a more detailed list can be found in [69].
Even if the major motivation behind breath gas analytical investigations
is the search for potential biomarkers of pulmonary diseases and pathophys-
iological disorders, there are a number of further applications. The ability
of continuous and on-line analysis (i.e., by means of proton-transfer-mass-
spectrometry (PTR-MS)) of exhaled breath [1,6,52–55] renders ongoing in-
formation on the current metabolic and physiological state of an individual.
Hence, it opens new areas of future applications like dynamic assessments of
normal physiological function or pharmacodynamics [3] and optimal control
of narcosis in anesthesiology [95].
Despite the promising diagnostic, prognostic and predictive potential of
biomarkers, breath analysis is a young field of research and has not yet
been widely accepted in clinical routine. Breath sampling, in particular, is
far from being a standardized procedure due to the numerous confounding
factors biasing the concentrations of volatiles in breath [2]. These factors
are related to both breath sampling protocols as well as complex chemical
and physiological mechanisms underlying biochemical pathways and exhala-
tion kinetics of VOCs. Even under resting conditions breath concentrations
of VOCs can strongly be influenced by specific physiological parameters
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(such as cardiac output and breathing patterns), depending on the physical-
chemical properties of the compound under study [10,22].
Breath marker Conditions
ethane lipid preoxidation, oxidatie stress, breast cancer,
heart transplant rejection
pentane lipid preoxidation, breast cancer
isoprene lung cancer, breast cancer, hypercholesterolemia,
oxidative stress
acetone diabetes mellitus, ketosis, halitosis
acetaldehyde lung cancer, alcohol consumption
methanol overgrowth of intestinal bacterial flora
ethanol overgrowth of intestinal bacterial flora,
alcohol consumption
2-propanol acetone reduction by bacterial flora, lung cancer,
breast cancer, stomach cancer
dimethylsulfide Intestinal bacterial flora, liver disorders,
oral infection
ammonia uremia, peptic ulcer, kidney disease
benzene lung cancer, breast cancer, smoke exposure
ethylene anesthetics inhalation
Table 1.1 – A selected list of breath biomarkers and related disorders [69].
In order to obtain diagnostically conclusive results, a thorough under-
standing of the physiological events and phenomena affecting exhaled VOC
levels as well as an appropriate choice of breath sampling conditions and
protocols are essential.
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For illustration of this point, consider the population study result in Fig-
ure 1.1, which may suggest the detection of lung cancer patients on the basis
of decreased isoprene levels in end-tidal breath.
Figure 1.1 – Overlay depicting the variability of end-tidal isoprene concen-
trations during hyperventilation of one single volunteer as compared to the
population boxplots associated with healthy test subjects and lung cancer pa-
tients, cf. [12].
Effectively, from the respective boxplots a tentative threshold value of
about 70 ppb differentiating between lung cancer patients and healthy vol-
unteers might be established. It should be noted, however, that from a
procedural point of view this observation will be of limited use, since any
further attempt to classify a specific individual will strongly depend on the
hemodynamic and respiratory status of the test subject investigated. Cor-
respondingly, by measuring end-tidal isoprene levels with breath-to-breath
resolution (cf. [53]), it can be demonstrated that a normal healthy volunteer
at rest might easily switch between the two groups defined above merely
by changing his breathing pattern, e.g., by breathing faster or by increasing
tidal volume. Doing so leads to an instantaneous drop of breath isoprene
levels, thereby hampering an unambiguous classification of this volunteer.
Such issues are further aggravated by the fact that human subjects tend to
hyperventilate when they are asked to breathe normally and provide a breath
sample [91]. Consequently, any screening study results like the one above
must be complemented by information on their variability with changes of
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ventilation, blood flow or pre-measurement conditions.
This paradigmatic example shows that a proper quantitative assessment
of the underlying exhalation kinetics is mandatory when aiming at the suc-
cessful introduction of a clinically applicable breath test.
In this context, mathematical modeling and simulation can be employed
for capturing the decisive quantitative features of the observable data. The
primary task of mathematical modeling hence is to provide a mechanistic de-
scription of the physiological phenomena governing the VOC under scrutiny
using all the experimental evidence available. Once such a model has been
developed it becomes possible to understand the key relationships underly-
ing the physiological behavior of the compound and to identify its defining
parameters. Such a quantitative approach can aid substantially in prevent-
ing misinterpretations of experimental results and in discovering errors and
omissions in earlier interpretations. Furthermore, these analyses can guide
the standardization and establishment of new sampling protocols, avoiding
potential confounding factors and maximizing the information content of
experimental results.
In the present work, we aim to establish the quantitive relationship be-
tween breath and the underlying endogenous blood/tissue concentrations of
isoprene. Beside the determination of physiological factors influencing the
gas exchange dynamics, an exhaustive understanding of the physiological
phenomenon can be achieved by describing the short-term effects of exhaled
dynamics in response to varying physiological conditions, which is mimicked
here by ergometer exercises.
In our experiments we have focused on two endogenous VOCs, isoprene
and acetone, which have received wide attention in the field of exhaled breath
analysis. These two compounds have contrasting physical-chemical proper-
ties (isoprene is strongly lipophilic whereas acetone is hydrophilic) and thus
can be considered as representative examples in a broad spectrum for model-
ing. While acetone will serve as an example for comparison and complement
in this part of the thesis, we refer to King et al. [55] for a corresponding model
and detailed analysis regarding acetone.
In the following we will briefly review some of the most important facts
that have provided a deeper understanding on the involved mechanisms
influencing the dynamics of isoprene and acetone in exhaled breath.
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1.2 A Survey on Physiological Relevant Facts
1.2.1 Cardiovascular and respiratory responses to dynamical
exercise
Physical exercise triggers a coordinated response of the respiratory and
cardiovascular systems. Due to the increasing activity and demands of skele-
tal muscles, exercise increases the demand for oxygen and the production of
carbon dioxide. To meet this increased demand, three primary physiologi-
cal changes take place: increased ventilation, increased cardiac output and
redistribution of cardiac output to enhance perfusion of exercising muscles.
The volume of fresh air moved into the lung from outside the body and
the volume of blood pumped by the heart per unit of time are referred to
as ventilation and cardiac output, respectively.
The increase in ventilation is nearly linear to both oxygen consumption
and carbon dioxide production up to a level of 60% of the subject’s maximal
work capacity. Above that level, ventilation increases faster than oxygen
consumption but continues to rise proportionally to the increase in carbon
dioxide production [62]. Even during mild to moderate exercise (aerobic
metabolism) the immediate increase in ventilation occurs too quickly to be
a response to alterations in metabolism or changes in the blood gases [62]
and therefore requires some other sensory input or central nervous system
mechanisms to be responsible. Two possibilities to explain this response are
neurally derived stimuli (feedforward control mechanism, a learned response
to exercise) and humorally derived stimuli (feedback response to exercise,
blood-borne stimuli) [42]. During heavy exercise (anaerobic threshold) the
respiratory drive may involve increased sensory inputs to the central venous
system which may be important in producing the additional increase in
ventilation [42].
Although the reason for the abrupt increase in ventilation at the begin-
ning of dynamical exercise remains uncertain, its presence is beyond doubt
and has been demonstrated by several investigators (see e.g., [42,62,67,118]).
The increase in ventilation is usually a result of increases in both tidal vol-
ume and breathing frequency. Initially, the tidal volume increases more than
the breathing frequency, but as metabolic acidosis develops, the increase in
breathing frequency predominates [62].
Cardiac output increases linearly with oxygen consumption during ex-
ercise. This normally occurs more as a result of an anatomically mediated
increase in the heart rate than from an increase in stroke volume. The mean
systemic pressure increases which in turn raises the pressure gradient for
venous return and local vasodilatation in the contracting muscles. As a con-
sequence the increased cardiac output is distributed preferentially to these
muscles [119]. Overall, cardiac output becomes more effective in supplying
exercising muscles with oxygen and metabolic substrates and in removing
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waste products. Increased perfusion of skin helps to remove the excess body
heat generated during exercise [42].
While overall ventilation can increase by approximately 20-fold during
maximal exercise, the heart increases its output by only about five times
that of its normal resting output. Therefore, it is the cardiovascular system
rather than the respiratory system that is the limiting factor in exercise of
healthy people.
1.2.2 Isoprene
Isoprene, also known as 2-methyl-1, 3-butadine (CAS number 78-79-5),
is a volatile liquid organic hydrocarbon with a boiling point of 34 ◦C, a high
vapor pressure of 60.7 kPa at 20 ◦C, and a molar mass of 68.11 g/mol. It is
used primarily for the synthesis of isoprene rubber and of copolymers with
styrene or with isobutene yielding rubbers with special properties [30].
Isoprene is a significant biosynthetic compound produced by plants, ani-
mals and bacteria. It is a fundamental structure of isoprenoid biochemicals,
which include cholesterol, other sterols, carotenoids, and Vitamin A. In hu-
man breath isoprene is the major hydrocarbon component [34] with concen-
trations of around 100 ppb [53,59,111] during rest. A circadian rhythm of
breath isoprene with an increase during the night has been observed [17,73].
Breath isoprene concentrations have been reported to be non-detectable
in the breath of neonates, while steadily increasing in teenagers and reaching
a plateau level in the middle age [90,103]. In young children exhaled breath
isoprene is demonstrably lower than in adults by a factor of about 2.4 [65].
Moreover, isoprene levels in older people appear to decrease [59,90].
The origin of human isoprene has been attributed to the mevalonate
pathway of cholesterol biosynthesis [24, 105]. Cholesterol is synthesized
practically in all our cells, however only the biosynthesis in the liver is sup-
posedly of crucial importance for the metabolism, which emphasises a hep-
atic production of isoprene.
The biosynthesis of cholesterol is a complicated process, but it can be
simplified to the following steps: Acetyl CoA (citric acid cycle) is a product
of the metabolism of any source of energy, be it protein, fat, or carbohydrate.
Initially three molecules of Acetyl-CoA are formed to mevalonate (mevalonic
acid) which is the rate-determining step for the whole biosynthesis and is
the site of action for statins. Mevalonate is then converted to form activated
isoprene. Six active isoprene molecules form squalene and finally squalene
is converted to cholesterol [44].
The synthesis of mevalonate from which isoprene is derived is inhibited
by statins. Statin drugs (”cholesterol-lowering” drugs) inhibit the synthesis
of mevalonate as has been demonstrated for lovastatin by Stone et al. [105]
and for atorvastation by Karl et al. [50]. The latter have shown that drug
administration results in a proportionally decline of breath isoprene concen-
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tration and the serum cholesterol levels and that cholesterol feeding, which
suppresses mevalonate formation, also lowers breath isoprene concentration.
In addition, cholesterol synthesis appears to occur mostly at night [75]. That
is why it is believed that isoprene concentration measurements could poten-
tially be used for mass screening for lipid disorders and to improve the care
of patients suffering from disorders in cholesterol metabolism, such as hy-
percholesterolemia.
On the other hand, several studies have pointed out that the effects of
statins extend beyond their cholesterol-lowering capacity. Myopathy is used
as a general term for diseases of the muscles. Myotoxic effects have been
reported to be a major adverse reaction to statin therapy, leading to the
inhibition of skeletal muscle activity and cell injury [27,29,116].
The extent to which the mevalonate pathway accounts for isoprene for-
mation under physiological conditions is still a matter of debate [73,107]. In
particular, the above-mentioned pathway rests on the acid-catalyzed solvol-
ysis of dimethylallyl-diphosphate in the liver which may be insignificant at
physiological pH values [100,101].
Other aforementioned clinical applications of breath isoprene relate to
end-stage renal disease (ESDR) [66], heart failure [71], acute myocardial
infarction [72] and lung cancer [12]. A brief overview of the potential appli-
cations of breath isoprene as a biomarker can be found in [96].
Isoprene is metabolized to monoepoxide and diepoxide intermedies by
liver microsomal cytochrome P450-dependent monooxygenases from several
species, including humans. Detoxification of these intermediates may occur
by hydrolysis (a chemical reaction or process in which a chemical compound
is broken down by reaction with water) catalyzed by epoxide hydrolase or
conjugation with glutathione catalyzed by glutathione-S-transferase [81].
Due to its volatility and low affinity for blood as reflected by a small
blood:gas partition coefficient λb:air = 0.75 at body temperature [30], iso-
prene exchange occurs mainly in the lung (see Section 1.4). Physical ac-
tivity causes strong changes in isoprene concentration in exhaled breath of
humans [50, 53, 99]. Real time measurements during moderate workload
ergometer challenges have been investigated by Karl et al. [50] and King
et al. [53] demonstrating an initial increase of breath isoprene in the first
minute of exercise by a factor of about 2 − 3 in mixed exhaled breath [50],
and by a factor of about 3 − 4 in end-tidal breath [53], respectively. Be-
cause of these characteristic rest-to-work transitions isoprene concentration
in exhaled breath might be interpreted as a potentially sensitive indicator
for fluctuations of blood and respiratory flow and can therefore be viewed
as a candidate for future assessments of hemodynamics, pulmonary function
and gas exchange patterns via observed exhaled behavior.
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1.2.3 Acetone
Acetone, also known as 2-propanone (or dimethyl ketone, β-keto-propane,
pyroacetic ether, CAS number 67-64-1) is a volatile, highly flammable liquid
with a boiling point of 56 ◦C, a vapor pressure of 24 kPa at 20 ◦C, and a
molar mass of 58.08 g/mol. Acetone is commercially produced by fermen-
tation of corn or from isopropyl alcohol, cumene or propane either as the
main product or as a by-product of chemical reactions [49].
Acetone is one of the most abundant compounds in human breath with
typical exhaled breath concentrations in the range of 500-1000 ppb in adults
[53,98,110]. So far no influences of sex, age, and BMI on breath concentra-
tions in adults could be detected [98].
In mammals 14C-carbons of labeled acetone have been found in liver
glycogen, urea, cholesterol, fatty acids and a substantial amount of 14C-
carbons has been recovered in vivo in exhaled carbon dioxide [49, 87] indi-
cating a metabolism of acetone intermediates. The two sources of acetone
production in the body are the decarboxylation of acetoacetate and the de-
hydrogenation of isopropanol. The former compound seems to be the major
source of acetone in mammals and arises from either lipolysis or amino acid
degradation [49]. Metabolic elimination occurs by conversion of acetone
into acetol by a cytochrome P450 isozyme. This isozyme is present in a
wide variety of tissues such as liver, kidney, spleen, and intestines [49].
Breath acetone increases during starvation-induced and diabetic ketone-
mia [87, 106], fasting, and high-fat diets [32, 78, 79]. Breath and plasma
acetone concentrations are nearly proportional [87], therefore breath ace-
tone is a suggested marker for monitoring the ketotic state of an individual.
Acetone has been used to assess the blood glucose level during a glucose
load by Galassetti et al. [33]. Additionally, elevated breath acetone levels
have been associated with congestive heart failure [58].
Acetone has a high water solubility, i.e., a blood:gas partition coefficient
λb:air = 340 at body temperature [10]. As demonstrated by Anderson et
al. [9, 10] this feature causes that upper airways take the primary role in
acetone gas exchange. The airway interaction leads to a decreased relative
elimination (expressed as the rate mixed venous to mixed alveolar partial
pressure or concentration) and thus to an underestimation of blood gas lev-
els. Rebreathed air (isothermal rebreathing) has shown to be a consistent
and representative measure of alveolar air concentration for acetone, while
end exhaled air of tidal breathing and prolonged expiration lead to an under-
estimation of alveolar air concentration by 30% and 20%, respectively [10].
Senthilmohan et al [99] reported slightly increased values under physical ex-
ercise. King et al [53] showed that exhaled acetone concentration during
exercise closely resembles the profile of alveolar ventilation.
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1.3 Real Time Measurements
The range of measurement techniques employed for breath gas analyt-
ical investigations is extremely diverse and each method comes with its
specific strengths and weaknesses [5, 18]. Within the present setting, we
will mainly focus on direct mass spectrometric techniques such as proton-
transfer-reaction mass spectrometry (PTR-MS). In brief, the latter has proven
to be a sensitive method for the quantification of volatile molecular species M
on the basis of chemical ionization within a drift chamber. More specifically,
it takes advantage of the proton transfer
H3O+ + M→ MH+ + H2O
from hydronium precursor ions originating from an adjoint hollow cath-
ode. Specifically, this reaction scheme is selective to VOCs with proton
affinities higher than water (166.5 kcal/mol), thereby avoiding the ioniza-
tion of the bulk composition exhaled air, N2, O2, and CO2. Count rates of
the nascent product ions MH+ or fragments thereof appearing at specified
mass-to-charge ratios m/z can subsequently be converted into absolute con-
centrations of the investigated compounds. Further details on quantification
can be found in [98].
A major hallmark of PTR–MS is its real-time capability, allowing for
the concentration measurement of VOCs with breath-by-breath resolution
(i.e., on a time-scale of less than 0.5 s). The possibility of generating high
frequency data can be viewed as an essential requirement for relating short-
term changes in breath VOC concentrations to quick physiological variations
(e.g., in blood or ventilatory flow). An experimental setup combining real-
time PTR–MS trace gas measurements with data streams reflecting hemo-
dynamic and respiratory parameters is shown in Figure 1.2.
The setup consists of five central parts:
• a hemodynamical monitor (Task Force Monitor) measuring heart rate,
heart minute volume, blood pressure, etc, on the basis of standard
ECG leads and transthoracic impedance cardiography (ICG),
• a spirometer (Medikro SpiroStar) measuring the volumetric flow rate
when breathing through a flow transducer of some form (e.g., a head
mask),
• a heated, chemically inert gas sample line leading from the flow trans-
ducer to the mass spectrometer,
• a medical semi-supine cycle ergometer for imposing certain workloads
on the test subject,
• the PTR-MS for measurement of volatile compounds in exhaled breath.
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Figure 1.2 – Experimental setup used for obtaining VOC profiles in conjunc-
tion with a number of physiological parameters [53].
Items in italic correspond to measurable variables. A selective and automated
analysis of predefined (e.g., end-tidal) breath segments is achieved by flow-
triggered sample extraction.
The test subject freely inhales/exhales through a flow transducers mouth-
piece, which is connected to a silicone head mask covering mouth and nose.
A detailed description of the experimental setup is given in [53]. The volume
of air inhaled or exhaled during normal breathing is called tidal volume. A
small proportion of the tidal volume contains the total volume of the con-
ducting airways, which do not contribute to gas exchange and it is therefore
called anatomical dead space. The respiratory flow effectively taking part in
pulmonary gas exchange (V˙A) is described by
V˙A = V˙E − V˙D , (1.1)
where V˙E represents the total minute ventilation and V˙D represents the total
dead space ventilation. While the measured VOC concentrations during
normal tidal breathing will provide the average composition of all the breath
sampled, end-tidal concentrations (the concentrations in the end-exhalation
volume) will approach the alveolar concentrations.
The above-mentioned instrumentation allows for the measurement of
end-tidal VOC concentration profiles. Respiratory flow is monitored contin-
uously during tidal breathing, which allows for a reliable breath-by-breath
detection of each end-tidal segments. Parallel to the breath measurements
several decisive physiological factors during rest, exercise challenges on a
cycle ergometer, and in a sleep laboratory setting can be performed.
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Such synchronized data streams are shown in Figure 1.3 and represent
an indispensable phenomenological basis pertinent to any quantitative mod-
eling approach. The data streams presented are taken from the study cohort
in [53] and are obtained from a single study subject during three different
exercise protocols on an ergometer. While an immediate and simultaneous
increase in alveolar ventilation and cardiac output can be observed in all
protocols at the onset of exercise, isoprene and acetone concentrations show
different profiles according to their physiochemical properties influencing
their gas-exchange dynamics.
Figure 1.3 – Typical results for one single test subject (male, 26 years)
Protocol 1: 5 min resting - 15 min exercise (75 W) - 3 min resting - 15 min
exercise (75 W) - 12 min resting - 5 min exercise (75 W) - 5 min resting,
Protocol 2: 5 min resting - 15 min exercise (75 W) - 12 min resting - 15 min
exercise (75 W) - 3 min resting - 5 min exercise (75 W) - 5 min resting,
Protocol 3: 5 min resting - 5 min supine position - 5 min resting - 5 min
exercise (50 W) - 5 min exercise (100 W) - 5 min exercise (50 W) - 10 min
resting)
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1.4 Modeling Pulmonary Gas Exchange
In the basic model describing the pulmonary gas exchange of blood borne
inert1 gases, the lung is assumed to be a homogenous single compartment
with an effective fixed storage volume V˜A of the gas considered. The effective
storage volume is larger than the gaseous volume of the lung because there
is also gas dissolved in the lung tissue (for the exact definition see Section
2.2.1). The rate of accumulation of gas in this volume equals the difference
between the transport into and out of this volume due to alveolar ventilation
V˙A and pulmonary perfusion (or cardiac output) Q˙c, which are modeled as
continuous2 and equal in inflow and outflow. This relationship is described
by the following mass balance equation (see, Section 2.2.1)
V˜A
dCA(t)
dt
= Q˙c(t) (Cv¯(t)− Ca(t)) + V˙A(t) (CI − CA(t)) (1.2)
in which Cv¯, Ca, CI, and CA are concentrations in mixed venous blood, arte-
rial blood, inspired air, and alveolar air, respectively. Here, the gas concen-
tration in inspired air is considered to be constant, while the expired air is
assumed to have the same concentration as the alveolar air. Moreover, it is
assumed that there is no diffusion limitation between pulmonary blood and
alveolar air implying that arterial blood and alveolar gas are in equilibrium
according to Henry’s Law (see Section A.2)
Ca = CAλb:air , (1.3)
where λb:air denotes the dimensionless partition coefficient between capillary
blood and alveolar air.
For an inert gas which is not present in the inspired air, i.e., CI = 0,
equations (1.2) and (1.3) yield the well known equation derived by Farhi [28]
for steady state conditions
CA =
Cv¯
λb:air + V˙A/Q˙c
. (Farhi’s equation) (1.4)
It expresses the fact that the concentration of an inert gas in the alveolar air
depends on the mixed venous concentration Cv¯, the dimensionless blood:air
partition coefficient λb:air, and the ventilation perfusion ratio V˙A/Q˙c. As it
can be easily seen from this equation, low soluble gases such as isoprene are
greatly influenced even by small fluctuations in ventilation or pulmonary
perfusion, while highly soluble gases such as acetone are not affected at
all. This compound-specific response to changes in ventilation and pul-
monary perfusion can also be seen in Figure 1.3. At the onset of exercise, a
1Here, the word inert refers to the property that the gas does not react chemically
with blood, and therefore is present only in physical solution
2That means that we take averages over a time period.
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peak-shaped profile of the end-tidal isoprene concentration can be observed,
whereas end-tidal acetone concentrations closely resembles the profile of the
alveolar ventilation.
There are two essential assumptions involved in the model of Farhi (1.4).
First, the diffusion across the alveolar membrane separating the capillary
blood from alveolar air space is not rate-limiting for alveolar gas exchange,
such that a complete concentration equilibrium is attained in the lung at
every instant. Although this assumption may be doubtful for gases of big
molecular weight and high solubility in blood, for inert gases it is fungible
[31, 113]. Second, the gases are well-mixed within the alveolar space. How-
ever, theoretical evidence appears to favor the existence of inhomogeneities
throughout the normal lung [42,118].
The ventilation-perfusion ratio (V˙A/Q˙c) refers to the ratio of alveolar air
to capillary blood received from an alveolar region and it can differ between
distinct regions of the lung. This is mainly caused by effects of gravity,
which results in a systemic gradient in both, ventilation and perfusion. Due
to the effects of hydrostatic pressure on the freely distensible pulmonary
vessels, the lower lung regions get a substantially larger blood flow than the
upper regions. The ventilation is also greater in the lower regions, because
alveolar ventilation depends on the difference between the maximum and
minimum volume of the alveolus during the breathing cycle, which is greater
in the lower regions. However, these effects do not exactly balance such
that the V˙A/Q˙c−ratio varies throughout the lung. Two well-known theories
regarding to the inhomogeneous lung refer to parallel and serial (stratified)
inhomogeneities.
We now take into account an inhomogeneous lung consisting of regions
with different V˙A/Q˙c− ratios, which are connected in parallel. Considering
the steady state relationship (1.4) for each different lung region, we see
that the lung eliminates various gases in different proportions. The ratios of
mixed arterial to mixed venous concentration (Ca/Cv¯) and mixed alveolar to
mixed venous concentration (CA/Cv¯) are defined as retention and excretion,
respectively. In an inhomogeneous lung, regions with a low V˙A/Q˙c−ratio
particularly increase the retention of low soluble gases, while, conversely,
regions with a high V˙A/Q˙c−ratio will mainly affect the retention of highly
soluble gases. This is also the basis for the Multiple Inert Gas Elimination
Technique (MIGET) introduced by Wagner [114] to determine a virtually
continuous V˙A/Q˙c distribution of the inhomogeneous lung (compartments
connected in parallel) by the simultaneous elimination of six different inert
gases with various solubilities.
Although MIGET is a useful technique for quantifying the ventilation-
perfusion inequality and pulmonary shunting, it has been shown by Olszowka
[82] that the calculated V˙A/Q˙c distribution using MIGET is not unique and
it is not necessarily the correct distribution since a number of considerably
different distributions may account for a given set of retention data. We will
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discuss the V˙A/Q˙c− inhomogeinity of the lung by means of a simple three
compartment model concerning isoprene in Chapter 4.
On the other hand, the term stratified inhomogeneity designates longi-
tudinal or serial concentration gradients in the airways due to incomplete
mixing of inspired with resident gas present in the lung in contrast to the
regional inhomogeneities implying concentration differences between paral-
lel lung regions. According to this theory developed by Scheid et al [97],
convection is the dominant transport mechanism in the upper airways while
axial diffusion is determining the gas exchange in terminal regions of the
lung so that there exists a diffusion limitation expressed in terms of dif-
fusion conductance (D), which is proportional to the diffusion constant of
the gas considered in the gaseous medium and is therefore specific for the
gas species. Stratified inhomogeneity reduces gas exchange efficiency by
producing an increase in retention and decrease in excretion of gases elimi-
nated from the blood, both effects being dependent upon the gas diffusivity
and blood solubility [42]. Regarding acetone, the diffusion conductance D
describes the diffusion limitation between the bronchial lining and alveolar
space, while for isoprene it refers to the diffusion limitation between prox-
imal and axial regions of the alveolar space. We will study the latter in
Chapter 4.
Furthermore, in these aforementioned studies, the gas exchange mech-
anism is restricted to the alveolar space by the assumption that no inert
gas is added to or withdrawn from the alveolar gas as it flows through the
airways during expiration. This is not true for highly soluble gases which
may readily dissolve in the bronchial lining and in the blood of bronchial cir-
culation. Anderson et al [9] have demonstrated that the blood:air partition
coefficient, λb:air, is a very important factor to determine the location of the
gas exchange in the lungs (airways versus alveoli). They have found that
low soluble gases (referred to as non-polar gases) with λb:air ≤ 10 exchange
almost solely in the alveoli, whereas for gases of high solubility (polar gases)
with λb:air > 10 the gas exchange in the airways plays the dominant role,
so that diffusion of gas through the airway tissue, bronchial blood flow, or
inspired air conditions are the important factors determining pulmonary gas
exchange3. Also the measure of heterogeneity of V˙A/Q˙c may be affected by
the same factors that affect the airway gas exchange.
According to their solubilities, it can be assumed that isoprene exchange
occurs almost exclusively in the alveoli whereas the majority of acetone ex-
change takes place within the conducting airways rather than in the alveoli,
which makes the acetone gas exchange mechanism less sensitive to the re-
gional inhomogeneities of the lung.
3Due to the high water content of blood, generally a strong correlation is assumed
between water:air and blood:air partition coefficients for polar gases and both are used
interchangeable.
CHAPTER 1. INTRODUCTION 18
To describe the breath isoprene dynamics under physical exercise, some
of the aforementioned modeling approaches will be studied in Chapter 4,
starting with the first developed physiologically based model for isoprene by
Filser et al. [30]. First, we will focus our interest on models considering func-
tional mechanisms of the lung, namely the serial lung model suggested by
Karl et al. [50], a three compartment parallel lung model (see, e.g., [43,45])
with regional ventilation-perfusion inhomogeneities, and a serial inhomo-
geneous lung model in terms of stratified inhomogeneity as suggested by
Scheid [97]. Subsequently, some insightful experimental results are presented
which lead to a new interpretation of the physiological formation of isoprene
and the first three compartment model developed by our research group [52].
This model will be then refined to capture the original compartmental seg-
mentation suggested by Filser and to explain further experiments.
Chapter 2
Physiological Modeling
2.1 Compartmental Mass Transport
Gas exchange processes in the human body involve the study of mass
transport phenomena between different parts of the organism, which are
interconnected through the circulatory system. Physiologically based com-
partment models have been widely used for this purpose to describe the
time-dependent distribution, absorption, metabolism and elimination of a
substance among different tissues. In general, one can always perform a de-
tailed analysis of the transport mechanism up to microvessels and cells level,
however, such an analysis requires a great deal of effort. On the one hand,
all the relevant information about the geometric structure and transport
properties are not available. On the other hand, such detailed considera-
tions render the numerical solutions expansive, are thus often unnecessary,
even impossible.
For this compelling reasons compartment models are mostly based on the
transport analysis at the organ level, where the compartments are defined
from physical properties corresponding either to specific, localized anatomic
structures (like lung, liver, kidney, etc.) or to type of tissues (such as fat,
muscle, viscera, bone, etc.) that are distributed throughout the body [8,20,
30, 77]. In most physical models all tissue of any given type is combined to
form a lumped compartment, as for example all fat in the body is lumped
into a single compartment with a total fat volume and total fat blood flow.
A typical example is shown in Figure (2.1).
Within the scope of the present work, we will confine ourselves to the
kinetically homogenous compartments regarding the systemic part of the
body, whereas spatially inhomogenous compartments of the respiratory tract
will also lie of the field of interest.
19
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16 CHAPTER 2. MODELING PRINCIPLES FOR VOC KINETICS
delicate preliminary task consists in identifying the basic mechanisms affecting an experimentally observed
behavior.
The issues raised above are inherent to quantitative assessments of VOC dynamics in the human body.
Nevertheless, like any physical system, these dynamics have to respect a set of fundamental laws that can
be employed for guiding the modeling process. An elementary but particularly useful tool in this context
is the concept of mass balance, coupled with a compartmental model design. A quite general formal
definition of a compartment has been given in [18] as follows: if a substance M is present in a system
in several distinguishable forms or locations and if M passes from one form or location to another form
or location at a measurable rate, then each form or location constitutes a separate compartment for M .
Similarly, a compartment might be seen as any discrete, functional unit of the investigated system in which
M can reasonably be postulated to behave uniformly. We shall refer to a compartment model as a set
of compartments interacting by exchanging material. In graphical representations, the compartments are
usually depicted as boxes, while an exchange mechanism between two compartments is indicated by a
directed arrow.
Within a physiological framework, the compartmental approach to mass transfer traditionally consists
in dividing the body into an ensemble of roughly homogeneous anatomic structures or tissue control vol-
umes that are interconnected via the arterial and venous network [131, 94, 9, 62, 54]. This yields a simpli-
fied representation of the human organism, reflecting known or hypothesized physiology and biochemistry.
A typical example is shown in Fig. 2.1.
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Figure 2.1: Physiologically based compartment model for the distribution of an endogenous volatile or-
ganic compoundM within the human body. Green items indicate known or measured variables according
to the experimental setup, while production, metabolism, storage, and depletion rates represent (unknown)
quantities that are expected to affect the tissue distribution ofM .
As has been indicated above, the number and configuration of the compartments defining such a physi-
ological model is seldom fixed a priori. In fact, the level of detail included will primarily be determined by
the physico-chemical characteristics of M , the (qualitative) features of experimental evidence as well as
Figure 2.1 – Physiologically based compartment model for the distribution
of an endogenous volatile organic compound within the human body.
The transport processes within these predefined compartments are speci-
fied by the laws of physics, i.e., the conservation of mass, stating that the rate
of accumulati n of mass in ach compartment equals the difference between
the transport of mass into the compartment and out of the com artment. In
physiological compartment models, the concentrations are treated as contin-
uous and thus the time-dependent course of compound in each compartment
is described by a mass-balance differential equations. Pharmacological and
physiochemical knowledge about the mechanism of transport, sites of action,
binding and solubility, etc. together with physiological data (determining
tissue volumes and blood flow rates) are used to formulate the model equa-
tions.
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2.2 Respiratory Gas Exchange
The lung is responsible for the gas exchange between the outside envi-
ronment and blood. This happens by means of ventilation, perfusion and
diffusion. Inhaled air passes along a branching network of progressively nar-
rower, shorter, and more numerous airways that end in smaller sacs called
alveoli. There are about 500 million alveoli in the human lung each with an
average diameter of about 300 µm at 75 % of maximum lung volume provid-
ing a very large surface area (approximately 70 m2) for gas exchange [118].
The pulmonary circulation carries the entire cardiac output of blood from
the right ventricle to the lungs for gas exchange. The main pulmonary artery
branches successively down to the the pulmonary capillaries. Pulmonary
capillaries (about 5 to 7 µm in radius) track along the alveolar walls, passing
several alveoli before the blood is collected in the venous system.
Pulmonary capillaries form a continuous network in the alveolar walls
throughout a lobe. When distended by intravascular pressure, they are
so numerous that blood flows almost as an unbroken sheet between the
airspaces. ”Sheet flow” reduces vascular resistance and optimizes gas ex-
change. When the pressure difference between the inside and outside of
the vessels (transmural pressure) is low, some of the capillary segments are
closed, but they are easily opened and recruited into the pulmonary vascular
bed by a transmural pressure increase. The open capillaries distend when
their transmural pressure rises, as when cardiac output increases [42].
In the lung, gas exchange occurs via passive diffusion along a partial pres-
sure gradient across the alveolocapillary membrane. The relative thinness
(about 0.1 to 0.5 µm) of this membrane allows for easy gas exchange.
2.2.1 Mass Balance Equation
To establish the conservation of mass, we consider a control volume
of constant size of the capillary blood (VD) that is bounded by alveolar
air space, where gas exchange occurs by the blood flow and the diffusion
between capillary blood and alveolar air. In the following, Cb and Cg denote
the concentrations, Pb and Pg the partial pressures of the substance in blood
and gaseous phase, respectively.
For the control volume VD, the mass of the dissolved gas contained in
this volume at any time is ∫ VD
0
Cb(v, t)dv .
The gas exchange between alveolar air and capillary blood is described
by a diffusion term with the assumption that the flow is linearly proportional
to the difference in partial pressures in gas (Pg) and in blood (Pb) across
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the interface and thus
q(v, t) = DL(Pb(v, t)− Pg(v, t)) , (2.1)
where DL is the diffusing capacity of the lung and includes the area, thick-
ness, and diffusion properties of the sheet and gas concerned (see Appendix
A.2). The net flux q(v, t) due to diffusion is negative when gas is flowing
from the dissolved phase to the gaseous phase. Since mass is conserved, we
have
d
dt
∫ VD
0
Cb(v, t)dv = Q˙c(t) (Cb(0, t)− Cb(VD, t))−
∫ VD
0
q(v, t)dt , (2.2)
where Q˙c(t) is the blood flow in the capillary at any time and is independent
of v.
Differentiating (2.2) with respect to VD and replacing VD by v and then
using (2.1), we obtain
d
dt
Cb(v, t) + Q˙c(t)
d
dv
Cb(v, t) = −DL(Pb(v, t)− Pg(v, t)) . (2.3)
Similar to (2.3), a mass balance equation for the gas contained in a
constant volume V ′D of alveolar air space
d
dt
Cg(v, t) + V˙A(t)
d
dv
Cg(v, t) = DL(Pb(v, t)− Pg(v, t)) , (2.4)
where V˙A(t) denotes the air flow through the borders of the volume, since for
the gas in the volume transport is by the air flow and the diffusion between
the capillary blood and the gas in alveolar space. Equations (2.3) and (2.4)
can be combined to give
d
dt
Cb(v, t) +
d
dt
Cg(v, t) = −Q˙c(t) ddvCb(v, t)− V˙A(t)
d
dv
Cg(v, t) . (2.5)
Gas Exchange in One Alveolus
We consider each differential volume of the alveolar air space as an alveo-
lus. Although Cg may vary with anatomic site in each alveolus, for simplicity
spatial gradients in concentrations are usually neglected, i.e., each alveolus
is assumed to be homogenous (or well-mixed, that is as if the alveolus is
stirred rapidly and the concentrations of all species in the alveolus remain
homogenous). Due to the high gas exchange efficiency of the lung diffu-
sion is assumed to be fast compared to the other dynamics influencing the
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system and an equilibration of the gas in alveolus with capillary blood is
achieved (in the absence of chemical bindings with blood) instantly accord-
ing to Henry’s Law (A.2). As an implication of the Mean Value Theorem of
analysis and denoting the constant concentration of the gas in inspired air
by CI from Equation (2.5) we get
d
dt
Cb(v, t) = −Q˙c(t) ddvCb(v, t) +
V˙A(t)
V ′D
(
CI − Cb(v, t)
λb:air
)
, (2.6)
where λb:air is the dimensionless partition coefficient between concentrations
in blood and in alveolus.
Gas Exchange Between Homogenous Compartments
A further approach to gas exchange modeling is to regard the alveolar
capillaries also as a homogenous compartment with a constant mean concen-
tration. According to this the gas exchange unit consist of two homogenous
compartments representing alveolar air and capillary blood. A permanent
diffusion equilibrium holds between these two compartments, i.e., Cb as well
as Cg instantaneously approach their steady state values. Due to this as-
sumption the diffusion terms on the right hand sides of equations (2.3) and
(2.4) equals zero. By denoting Cb(0, t) = Cb,in(t) and C?(VD, t) = C?,out(t)
1 the combination of (2.3) and (2.4) simplifies to the following ordinary
differential equation (ODE) which depends only on time
V˜D
d
dt
Cg(t) = Q˙c(t) (Cb,in(t)− Cb,out(t)) + V˙A (CI − Cg,out(t)) . (2.7)
The factor V˜D := V ′D + VDλb:air can be interpreted as ”effective” volume of
the combined compartment.
2.3 Gas Exchange in Systemic Compartments
In physiologically based compartment models the systemic part of the
body is subdivided in organs or tissues as mentioned before. These com-
partments are connected by blood flow in parallel. The rational selection of
the size and number of compartments depends on the specific compound.
A bride spectrum of approaches from detailed models containing all known
factors influencing the system to more simplified models eliminating some
organs or representing them in a lumped compartment can be chosen with-
out losing the ability to describe specific datasets.
1here ? denotes g or b
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Compartments are considered to consist of three well-mixed subcom-
partments representing the vascular part through which the compartment
is perfused with blood, cellular space comprising the cells of the organ, and
an interstitial space connecting them. Mass transfer between these com-
partments occurs by diffusion. When one of the steps in mass transport
is rate limiting, e.g., diffusion between the subcompartments occurs very
rapid compared to the perfusion rate to the tissue (flow-limited assump-
tion), the compartment may be simplified from the three-subcompartment
model to a model with one or two subcompartments (for a detailed descrip-
tion see [35]). We will use here the latter approach of one perfusion limited
well-mixed compartment assuming a rapid diffusion equilibrium between the
vascular, interstitial, and cellular compartments. The compound enters the
compartment in the arterial blood and leaves it in the venous blood. Due
to the diffusion equilibrium across the tissue membranes, the venous blood
leaving the compartment is considered to be in equilibrium with the com-
partmental concentration at every instant. The relationship between the
single compartment concentration (C) and eﬄuent venous blood (Cv)
Cv = λb:tC (2.8)
is called venous equilibrium assumption, where λb:t is the partition coeffi-
cient between blood and and compartment. This assumption is referred to
as blood-flow-limited uptake.
In some compartments, metabolic activities such as production and
metabolic elimination may take place, thus gain or loss of the compound
should be considered. Tissue retention of organic compounds is related to
blood:tissue partition coefficients λb:t and the presence of specific binding
proteins in the tissues. Elimination is regulated by pulmonary dynamics for
exhalation, by kinetic constants of metabolizing enzymes (found principally
in liver), and to a much lesser extent by renal filtration mechanisms [8].
Metabolic elimination is usually described either by first order kinetic or
saturable Michaelis Menten kinetic. In case of high concentrations of com-
pound in inhaled air, the saturable metabolic elimination in compartment
is given by
Vmaxλb:tC
Km + λb:tC
(2.9)
with a maximum rate of metabolism for this compound Vmax and Michaelis-
constant Km. Here, C denotes the compartmental concentration of the
compound and λb:t is the compartment specific blood:tissue partition coef-
ficient.
If the ambient is nearly free of the substance, the rate of metabolic elimina-
tion is approximated by
Vmax
Km
λb:tC = kmetλb:tC , (2.10)
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where kmet denotes the rate of metabolic elimination.
The mass balance equation for a compartment with a constant production
rate and a metabolic elimination described by linear kinetic reads
V˜
dC(t)
dt
= q Q˙c(t) (Ca(t)− λb:tC(t))− kmetλb:tC(t) + kpr , (2.11)
where Ca is the arterial concentration, q is the fractional flow rate of blood
to the tissue compartment, and kpr is the production rate. The effective
compartment volume is defined by V˜ := V + Vt,b λb:t with tissue volume V
and blood volume contained in the tissue compartment Vt,b.
As defined in Equation (2.8), the term λb:tC determines the concentra-
tion of venous blood leaving the compartment. Thus, the total mixed venous
concentration is calculated by blood flow-weighted averaging of all consid-
ered compartments. By a number of N compartments, the total mixed
venous concentration reads
Cv¯(t) =
∑
N
qN λb,N CN (t) . (2.12)
Chapter 3
Model Structure and
Properties
The essence of the modeling process is to derive a mechanical description
of the underlying real system, which delivers the best possible understanding
of the biological phenomenon, allows all the known experimental data to be
taken into account and makes it possible to understand what components
and interactions are important in the originating complex system. Once such
a model structure is chosen, one is usually confronted with the identification
of model parameters, which could not be directly measured and have to
be estimated from measured data. In the following we will review some
methodological aspects of the modeling process and parameter estimation.
In the context of VOC modeling, compartmental considerations as de-
scribed in Chapter 2 together with an appropriate input-output configura-
tion and a fully determined set of parameters corresponding to the system
will lead to the following deterministic description of the underlying physical
system
x˙ = f(t,x,u,p), with x(t0) = x0, (3.1)
y = h(t,x,u,p), (3.2)
where the state variable x evolves in an open set D of the n-dimensional
space Rn, y ∈ R is the measurement (or output), u ∈ Rr is the known
system input vector, and p ∈ Rq is the constant parameter vector. The
observation interval is denoted by I = [t0, t1].
In the present context, x typically reflects molecular concentrations of
the trace gas under consideration within the blood/tissue compartments in-
troduced, u describes external (constant or time-varying) inputs (like flows,
temperature, etc.), and the constant unknown parameter vector consists of
in vivo kinetic rate constants (like production rates or metabolic elimination
rates) or compartment volumes to be estimated. The scalar measurement
26
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equation (3.2) contains the information on the model dynamics collected by
experiments according to a fixed experimental setup.
In the following we assume that f(·) and h(·) are continuous in t and
continuously differentiable with respect to state x and parameters p. The
external input vector u is postulated to be uniformly bounded over I. Some
constraints according to the model structure are usually available
g(t,x,u,p) ≥ 0, (3.3)
where g is a vector of polynomial functions describing all the algebraic (linear
or nonlinear) equality and inequality constraints among the components of
x, u and p, which are known a pripori.
The equations (3.1)-(3.3) define a complete constrained structure. On the
basis of measurements, the task is to determine the unknown initial state
x0 and the constant parameter vector p.
3.1 Qualitative Properties of the Model
The solution of the initial value problem (3.1) has to fulfill some qual-
itative requirements, like existence, uniqueness, continuous dependence on
initial conditions, and continuous dependence on parameters, for the model
to be a useful description of a physical system.
Let us consider the general state equation (given, e.g., by substituting the
inputs which are specified as a function of t), where f : I × D → Rn is
continuous in t and continuously differentiable with respect to x, and
x˙ = f(t,x), with x(t0) = x0 . (3.4)
A continuously differentiable function x : I → D is said to be a solution to
(3.4) on the interval I ⊆ R with initial condition x(0) = x0 ∈ D if and only
if x(t) satisfies (3.4) for all t ∈ I. We denote the solution to the initial value
problem (IVP) (3.4) by φ(·,x0), so that the flow of the dynamical system
(3.4) is given by the map φ : I ×D → D and is continuous and continuously
differentiable in t.
3.1.1 Existence and Uniqueness of Solutions
For the mathematical model to predict the future state of the system
from its current state, the IVP must have a unique solution. The unique
existence of solutions of the IVP (3.4) can be ensured by imposing some
constraints on the right-hand side function f(t,x). In fact, continuity of
f(t,x) in its arguments ensures that there exist at least one solution, but, it
is not sufficient to ensure the uniqueness of the solution. The key constraint
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used to prove uniqueness is the Lipschitz condition, whereby f(t,x) satisfies
the inequality
‖f(t,x)− f(t,y)‖ ≤ L‖x− y‖ (3.5)
for all (t,x) and (t,y) in some neighborhood of (t0,x0).
For f continuous in t and locally Lipschitz continuous in x, according to the
Theorem of Picard Lindelo¨f (see, e.g., [41]) it can be shown that there exist
some δ > 0, such that the IVP (3.4) has a unique solution over [t, t+ δ]. In
fact, δ may be small so that local Lipschitz continuity cannot guarantee the
existence and uniqueness of the solutions over a given time interval [t0, t1].
The interval of existence may be extended by repeated applications of the
local Picard Lindelo¨f theorem, however, in general, it cannot be extended
indefinitely. There is a maximum interval [t0, T ) where the unique solution
exists. In general, T may be less than t1, in which case as t → T , the
solution leaves any compact set over which f is locally Lipschitz in x.
The existence and uniqueness of the solution over the interval [t0, t1], where
t1 may be arbitrarily large, can be proved by requiring f to satisfy a global
Lipschitz condition. That is, if f satisfies the inequality (3.5) for all x,y ∈
Rn and is uniformly in t for all t ∈ [t0, t1], then the IVP (3.4) has a unique
solution over [t0, t1].
Remark 1. Consider the linear system x˙ = A(t)x + g(t) = f(t,x), where
A(t) and g(t) are continuous functions of t. Over any finite interval of time
[t0, t1], the elements of A(t) are bounded and the conditions of the global
existence and uniqueness are satisfied. Therefore, the linear system has a
unique solution over [t0, t1].
Remark 2. The Lipschitz property of a function is a stronger condition than
continuity but weaker than continuous differentiability. Thus, for the case
where f is continuous differentiable, local Lipschitz continuity is implied,
which ensures the local existence and uniqueness of the solution of the IVP
(3.4). On the other hand, if [∂f/∂x] is bounded by a constant k over the
interval of interest, then f is Lipschitz on the same interval with Lipschitz
constant L = k, and a unique solution exists over the interval of interest.
Although for linear systems the global Lipschitz condition is a reasonable
requirement, it is restrictive and models of many nonlinear systems may fail
to satisfy it though they have unique global solutions. At the expense of
having to know more about the solution of the system the following global
existence and uniqueness theorem achieves, that requires the function f to
be only locally Lipschitz [51].
Theorem 3.1.1. Let f(t,x) be continuous in t and locally Lipschitz in x
for all t ≥ t0 and all x in a domain D ⊂ Rn. Let M be a compact subset
of D, x0 ∈ M, and suppose it is known that every solution of (3.4) lies
entirely in M. Then, there is a uniqie solution that is defined for all t ≥ t0.
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The trick in applying the Theorem 3.1.1 is to check the assumption that
every solution lies in a compact set without actually solving the differential
equation. Lyapunov’s method for studying stability is very valuable in this
respect.
3.1.2 Continuous Dependence on Initial Conditions and Pa-
rameters
An essential factor for the validity of any mathematical model is the
continuous dependence of its solutions on the data (initial states and pa-
rameters) of the problem. The least we should expect is that arbitrarily
small errors in the data will not result in large errors in the solutions ob-
tained by the system.
The solution of the IVP (3.4) defined on a compact time interval depends
continuously on its initial state if solutions starting at nearby points are
defined on the same interval and remain close to each other on that interval.
Continuous dependence on parameters is defined similarly. Let φ(t,x0,p0)
be a solution of x˙ = f(t,x,p0) defined on I = [t0, t1], with φ(t0,p0) = x0.
The solution is said to depend continuously on p if for any ε > 0, there exists
a δ > 0 such that for all p in the ball {p ∈ Rq | ‖p− p0‖ < δ}, the equation
x˙ = f(x,p) has a unique solution φ(t,p) defined on I, with φ(t0,p) = x0,
and satisfies ‖φ(t,p)− φ(t,p0)‖ < ε for all t ∈ I.
The continuous dependence on initial conditions and parameters can be
studied simultaneously as stated by the following theorem [51].
Theorem 3.1.2. Let f(t,x,p) be continuous in (t,x,p) and locally Lips-
chitz in x (uniformly in t and p) on I ×D×{‖p−p0‖ ≤ c}, where D ⊂ Rn
is an open connected set. Let φ(t,p0) be a solution of x˙ = f(t,x,p0) with
φ(t0,p0) = x0 ∈ D. Suppose φ(t,p0) is defined and belongs to D for all
t ∈ [t0, t1]. Then, given ε > 0, there is δ > 0 such that if
‖z0 − y0‖ < δ and ‖p− p0‖ < δ
then there exist a unique solution z(t,p) of x˙ = f(t,x,p) defined on [t0, t1],
with z(t0,p) = z0, and z(t,p) satisfies
‖z(t,p)− y(t,p0)‖ < ε, ∀t ∈ [t0, t1] .
Remark 3. If f is continuous in its arguments and has continuous first
partial derivatives with respect to x and p, we know from Theorem 3.1.2
the local unique existence of solutions and continuous dependence of initial
values and parameters. Thus, well-posedness property of the system results
by showing the uniform boundedness of the Jacobian of f with respect to
x over the interval of interest.
CHAPTER 3. MODEL STRUCTURE AND PROPERTIES 30
Remark 4. The continuous differentiability of f with respect to x and p im-
plies the additional property that the solution x(t,p) is differentiable with
respect to p near p0. We use this property to calculate the sensitivity equa-
tions which provide first-order estimates of the effect of parameter variations
on solutions.
3.1.3 Stability of Equilibrium Points
Stability of equilibrium points is usually characterized in the sense of
Lyapunov. Consider the autonomous system
x˙ = f(x) (3.6)
where f : D → Rn is locally Lipschitz. Assume that solutions of (3.6) are
defined for all t ≥ 0. Suppose xe ∈ D is an equilibrium point of (3.6); that
is, f(xe) = 0. For convenience, we consider the case when the equilibrium
point is at the origin of Rn; i.e., xe = 0 and f(x) satisfies f(0) = 0 and we
will study the stability of the origin x = 0.
An equilibrium point is stable if all solutions starting at nearby points
stay nearby; otherwise it is unstable. It is asymptotically stable if all so-
lutions starting at nearby points not only stay nearby, but also tend to
the equilibrium point as time approaches infinity. These notions are made
precise in the next definition.
Definition 1. The equilibrium point x = 0 of (3.6) is
• stable if, for each ε > 0, there exists a δ = δ(ε) > 0 such that
‖x(0)‖ < δ ⇒ ‖x(t)‖ < ε , ∀t ≥ 0 ,
• unstable if it is not stable ,
• asymptotically stable if it is stable and δ can be chosen such that
‖x(0)‖ < δ ⇒ lim
t→∞x(t) = 0 .
Lyapunov stability theorems give sufficient conditions for stability and
asymptotic stability.
Theorem 3.1.3. (Lyapunov’s Theorem) Let V : D → R be a continuously
differentiable function such that
V (0) = 0 and V (x) > 0 in D − {0} . (3.7)
The derivative of V along the trajectories of (3.6), denoted by V˙ (x), is given
by
V˙ =
n∑
i=1
∂V
∂xi
x˙i =
n∑
i=1
∂V
∂xi
f i(x) .
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If
V˙ (x) ≤ 0 in D , (3.8)
then the equilibrium solution x(t) ≡ 0 is stable. Moreover, if
V˙ < 0 in D − {0} , (3.9)
then the equilibrium solution x(t) ≡ 0 is asymptotically stable. Finally, if
D = Rn and V (·) is such that
V (x)→∞ as ‖x‖ → ∞ (3.10)
then the equilibrium solution x(t) ≡ 0 is globally asymptotically stable.
In cases where the Lyapunov function fails to satisfy the asymptotic
stability condition of Theorem 3.1.3 because its derivative is only negative
semidefinite, the Krasovskii-LaSalle invariance principle can be used to relax
the strict negative-definiteness condition on the Lyapunov derivative while
ensuring system asymptotic stability [37,51]. First we introduce a few defi-
nitions.
Let x(t) be a solution of (3.6). A point p is said to be a positive limit
point of x(t) if there exists a sequence {tn}, with tn → ∞ as n → ∞, such
that x(tn) → p as n → ∞. The set of all positive limit points of x(t) is
called the positive limit set of x(t). A set D is said to be an invariant set
with respect to (3.6) if
x(0) ∈ D ⇒ x(t) ∈ D, ∀t ∈ R .
That means, if a solution belongs to D at some time instant, then it belongs
to D for all future and past time. A set D is said to be a positively invariant
set if
x(0) ∈ D ⇒ x(t) ∈ D, ∀t ≥ 0 .
We can now formulate the following theorem:
Theorem 3.1.4. (Krasovskii-LaSalle’s theorem) Let Dc ⊂ D be a compact
set that is positively invariant with respect to (3.6). Let V : D → R be a
continuously differentiable negative-semidefinite Lyapunov function in Dc.
Let E be the set of all points in Dc where V˙ (x) = 0 and let R be the largest
invariant set in E. Then, every solution starting in Dc approaches R as
t→∞.
When our interest is to show that x(t) → 0 as t → ∞, we need to
establish that the largest invariant set in E is the origin. This is done by
showing that no solution other than the trivial solution x(t) ≡ 0 can stay
entirely in E . Specializing Theorem 3.1.4 to this case and taking V (x) to be
positive definite, we obtain the following corollary:
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Corollary 3.1.1. Let x = 0 be an equilibrium point for (3.6). Let V : D →
R be a continuously differentiable positive definite function on D containing
the origin x = 0, such that V˙ (x) ≤ 0 in D. Let N = {x ∈ D | V˙ (x) = 0}
and suppose that no solution other than the trivial solution x(t) ≡ 0 can
stay entirely in N . Then, the origin is asymptotically stable.
Remark 5. The linear time-invariant (autonomous) system
x˙ = Ax (3.11)
has an equilibrium point at the origin. The equilibrium point is isolated
if and only if det(A) 6= 0 and the stability properties of the origin can
be characterized by the locations of the eigenvalues of the matrix A. The
equilibrium point x = 0 is stable if and only if all eigenvalues of A satisfy
Reλi ≤ 0 and for every eigenvalue with Reλi = 0 and algebraic multiplicity
qi ≥ 2, rank(A−λiI) = n−qi, where n is the dimension of x. The equilibrium
point x = 0 is (globally) asymptotically stable if and only if A is Hurwitz ;
that is, all eigenvalues of A satisfy Reλi < 0.
For nonlinear systems, the local asymptotical stability of equilibrium
points of the system can be reduced to show the local asymptotical stability
of the linearized system around the equilibrium point by using the theorem
of Lyapunov’s indirect method (see, e.g., [51]).
3.1.4 Compartmental Systems
In physiological compartment models with well-mixed compartments,
the mass contained in the compartment is expressed by xi = vi ci, where vi
is the strict positive constant compartment volume and ci denote the concen-
tration in compartment i. For an n compartment system the instantaneous
mass balances for each compartment i are expressed by the following set of
equations
x˙i = vi c˙i =
∑
j 6=i
fji −
∑
k 6=i
fik − ei + bi, i = 1, . . . , n , (3.12)
where the mass transfers, called flows or fluxes, from compartment i to
compartment j are denoted by fij . Additional inflows bi and ei represent the
interactions of compartment i with its periphery. For each compartment i
this equation expresses the fact that the rate of accumulation of the quantity
xi is just the difference between the inflows fij , bi and the outflows fik, ei.
An example of a compartmental system is given in Figure 3.1. A detailed
analysis of compartmental networks can be found in [15,47], from where the
below-mentioned results and designations are partly taken.
All flow functions are defined to be non-negative on the non-negative or-
thant, i.e., fij , bi, ei ∈ R+ for all t. The signs in (3.12) indicate the direction
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of flow, and all flow functions for non-existing links do not appear in the
equations. Generally, the inflows bi are constant, while fij and ei can be
functions of the state variable c and possibly t.
Since there cannot be negative concentrations, the quantities ci must always
be non-negative, i.e., c ∈ Rn+ for all t. Moreover, it is clear that there cannot
be a positive outflow from an empty compartment, i.e.,
ci = 0⇒ fij = 0 and ei = 0. (3.13)
690 G. Bastin, V. Guffens / Systems & Control Letters 55 (2006) 689–696
for analysing hop-by-hop congestion control strategies.
The congestion control approach followed in this paper is
different: it illustrates that compartmental ???d ?ow mod-
elling can also be used to address the so-called end-to-end
congestion control problem.
Compartmental network systems are ?????d in Section 2.
They have numerous interesting structural properties which are
well documented in the literature (see the references). Some of
these properties which are useful for our purpose are ??????
reviewed in Section 2. In particular, the equilibrium stability
properties of cooperative compartmental systems are empha-
sized. Our contribution is in Section 3, where the proposed
controller is presented. The main properties of the closed loop
system and the controller are studied. It is shown that the two
main objectives of the congestion control are achieved: (i) a
demand which is not in excess is automatically ???????d but (ii)
in case of an excess demand, an operation without ov???ow is
automatically guaranteed. Furthermore, if the controlled net-
work is cooperative, then the closed loop system has a unique
globally asymptotically stable equilibrium. A brief simulation
experiment is used in Section 4 to illustrate the validity of the
control scheme and some design issues. Some ???l comments
are given in Section 5.
2. Compartmental network systems
A compartmental network system is a network of con-
ceptual storage tanks called compartments as illustrated in
Fig. 1. Each node of the network represents a compartment
which contains a variable quantity xi (t) of some material
or immaterial “species” involved in the system. The vector
x(t) = (x 1(t ), x 2(t ), . . . , x n(t)) T is the state vector of the sys-
tem. Each directed arc i j represents a mass transfer which
may hold for various transport, transformation or interaction
phenomena between the species inside the system. The trans-
fer rate, called ??? or ???, from a compartment i to another
compartment j is a function of the state variables denoted
f ij (x(t)) . Additional input and output arcs represent the in-
teractions with the surroundings: either ???ows bi (t) injected
from the outside into some compartments or ????ows ei (x(t))
from some compartments to the outside.
The instantaneous ?ow balances around the compartments
are expressed by the following set of equations:
x˙i =
j = i
f j i (x) −
k= i
f ik (x) − ei (x) + bi , i = 1, . . . , n .
(1)
These equations express that, for each compartment, the rate
of accumulation of the quantity xi is just the difference be-
tween the ???ow rates f j i , bi and the ????ow rates f ik , ei .
In the equations, only the terms corresponding to actual links
of the network are made explicit. Otherwise stated, all the
bi , ei and f ij for non-existing links do not appear in the
equations.
1
5
2
4
3
b5
f12
f21
f54
f24
e2
f23
f43
e3
b1
Fig. 1. Example of compartmental network.
The model (1) makes sense only if the state variables xi (t)
remain non-negative1 for all t : xi (t) R + . The ?ow functions
f ij and ei are ?????d to be non-negative on the non-negative
orthant f ij : R n+ R + , ei : R n+ R + . Similarly, the ???ows
bi are ?????d to be non-negative bi (t) R + t. Moreover, it
is obvious that there cannot be a positive ?ow from an empty
compartment
xi = 0 f ij (x) = 0 and ei (x) = 0. (2)
Under condition (2), if f ij (x) and ei (x) are differentiable, they
can be written as
f ij (x) = rij (x)x i , ei (x) = qi (x)x i
for appropriate functions rij (x) and qi (x) which are ??????
on R n+ , non-negative and at least continuous. These functions
are called ??????c ???? (or also fractional rates). In this paper,
we shall assume that the ??????c ?ows rij (x) and qi (x) are
continuously differentiable and strictly positive functions of
their arguments in the positive orthant:
rij (x) > 0 and qi (x) > 0 x R n+ .
In other words, we assume that the ?ows f ij and ei vanish only
if xi = 0. It is a natural assumption which is ???????d in many
physical and engineering models described by compartmental
models.
With these ?????????s and notations, the compartmental sys-
tem (1) is written
x˙i =
j = i
rj i (x)x j −
k= i
rik (x)x i − qi (x)x i + bi
i = 1, . . . , n )3(.
State-space models of this form are used to represent, for
instance, industrial processes (like distillation columns [25],
chemical reactors [17], heat exchangers, grinding circuits [11]),
queuing systems [8] and communication networks [12], eco-
logical and biological processes [19,26], etc.
1 Notation. The set of non-negative real numbers is denoted R + = { a
R , a 0} as usual. For any integer n, the set R n+ is called the “positive
orthant”.
Figure 3.1 – Example of a compartmental system taken from Bastin [15].
Under th co dition (3.13), if fij and ei are k-times con i uously differ-
entiable, i.e., Ck, we can write them as
fij = rijci, ei = qici (3.14)
for appropriate functions rij and qi which are defined on Rn+, non-negative
and at least Ck−1. These functio s are called fractional rates.
In the scope of physiological compartment models considered in this thesis,
we will assume that the fractional rates are smooth and strictly positive
functions in their arguments. In other words, we assume that the flows rij
and qi vanish only if ci = 0.
With these definitions and notations, the compartment system (3.12) is
written as
vic˙i =
∑
j 6=i
rjicj −
∑
k 6=i
rikci − qici + bi i = 1, · · · , n . (3.15)
From this equation, we can easily obtain that, when ci = 0, ci ≥ 0 for all t
regardless of the values of cj for i 6= j. Thus, the positive orthant Rn+ is a
forward invariant set for the ystem (3.15). That is; if c ∈ Rn+ and ci = 0,
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then
c˙i =
1
vi
∑
j 6=i
rjicj + bi
 ≥ 0 . (3.16)
Moreover, by considering the total mass contained in the system m :=∑
i vici, we see that
m˙ =
∑
i
vic˙i =
∑
i
(bi − qici) for i = 1, . . . , n , (3.17)
and thus the trajectories of the system remain bounded for bounded t in-
tervals if bi are bounded functions of time for all i.
The system (3.15) can be written in matrix form as
c˙ = vAc+ vb , (3.18)
where v = diag( 1v1 , . . . ,
1
vn
), b is the n × 1 vector of functions bi and A is
known as compartmental matrix with the following properties:
• A has non-negative off-diagonal entries
aij = rji ≥ 0 for i 6= j. (3.19)
Systems with this property are referred to cooperative systems. If the
fractional transfer coefficients are constant, (3.19) represents a linear
system with constant coefficients and A is called a Metzler matrix.
• A has non-positive diagonal entries
aii = −qi −
∑
j 6=i
rij ≤ 0. (3.20)
• A is diagonally dominant corresponding to its columns
|aii| ≥
∑
j 6=i
aji. (3.21)
By inserting the elements of A into (3.21) we see that
|aii| = | − qi −
∑
j 6=i
rij | ≥
∑
j 6=i
|rij | , (3.22)
and thus, the equality in the diagonal dominancy of A expressed in (3.21)
holds only for a compartment system which has no outflows, called outflow
closed system. In this case, qi’s disappear in (3.22) and each column of A
sums to zero. This, in turn implies that A is always a singular matrix for
outflow closed systems. Otherwise, if at least one of the compartments has
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an outflow, the system is called open and the matrix A is a nonsingular,
strict diagonally dominant matrix.
If A is a constant matrix, by considering the sign of the diagonal elements
of A, we can conclude for open systems from the Theorem of Gershgorin (see,
e.g., [93]), that all eigenvalues of A have negative real parts. This conclu-
sion follows from the fact that every eigenvalue of A lies in a circle (called
Gershgorin disc) centered at aii with radius sum of the norms of the other
elements on the same row
∑
j 6=i aij . Since we know that the eigenvalues of A
are the same as the eigenvalues of AT , it follows that every eigenvalue of A
must lie in a Gershgorin disc corresponding the columns of A. Because A is
a diagonally dominant Metzler matrix with non-positive diagonal elements,
A has only eigenvalues λi with Re(λi) ≤ 0, and for qi 6= 0, all eigenvalues of
A satisfy Re(λi) < 0.
Showing that the eigenvalues of the system matrix vA have the same prop-
erty is equivalent to show that vA is similar to a diagonally dominant Met-
zler matrix C with non-positive diagonal entries, since we know that similar
matrices share the same eigenvalues.
Thus, we must prove that there exists a nonsingular matrix T with
C = T (vA)T−1. By choosing T = diag(v1, . . . , vn) it can be shown that
C = T (vA)T−1 = (aij/vj)i,j=1,...,n , (3.23)
which is also a Metzler matrix with non-positive diagonal elements. It is ob-
vious that the diagonal dominancy of C results from the diagonal dominancy
of A since
cii +
∑
j 6=i
cji =
1
vi
aii +∑
j 6=i
aji
 ≤ 0 (3.24)
for vi > 0. According to the argumentation from above, the real parts of the
eigenvalues of C, and consequently of vA, are non-positive and are strictly
negative for open systems.
Furthermore, for constant A and constant inflows bi, the total mass m fulfills
the requirements of a Lyapunov function, since m satisfies
m(0) = 0 , m(c) > 0 for c 6= 0 and (3.25)
m˙(c) =
∑
i
−qici ≤ 0 for c 6= 0 . (3.26)
Although the concentrations of outflow closed compartments do not appear
in the right-hand side of (3.26), from equations (3.15) it is obvious that
the system can maintain the m˙(c) condition only at the origin. Therefore
m(c) must decrease toward 0 and consequently c(t) → 0 as t → ∞. To
summarize, for constant A, the homogenous system is asymptotically stable
and also the inhomogeneous system with constant inputs will have the same
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property.
For nonlinear systems, the local asymptotical stability of equilibrium
points of the system can be reduced to showing the local asymptotical sta-
bility of linearized system about the equilibrium point by using Lyapunov’s
indirect method (see e.g. [51]).
For nonlinear compartmental systems with constant transfer coefficients
which have a unique equilibrium point, even the global asymptotic stability
of the equilibrium point can be shown by means of the theorem given by
Leenheer [61]. A well-known result on systems of this type asserts that the
associated semiflow φ : R+ ×Rn+ → Rn+, (t, c0) 7→ φ(c0) := c(t) is monotone
with respect to the natural (componentwise) partial order on Rn+ given by
c ≤ z if and only if ci ≤ zi , i ∈ {1, . . . , n}. (3.27)
That is, φ preserves the order of the initial conditions (see [104], Prop.
3.1.1), i.e., for c0, c¯0 ∈ Rn+ the condition c0 ≤ c¯0 implies that φt(c0) ≤ φt(c¯0)
for t ∈ [0,∞). As a third requirement, since all trajectories are bounded
and the system evolves within a closed state space D ⊂ Rn+ it follows that
for every c ∈ D the corresponding semi-orbit O(c) := {φt(c), t ≥ 0} has
compact closure. In summary, we are now in position to apply Theorem 5
of Leenheer et al. [61], which asserts that the aforementioned properties are
sufficient for the unique equilibrium point in D to be globally attractive [55].
3.2 Optimization and Parameter Identifiability
One of the fundamental questions of parameter identification is whether
or not the parameters in the present system can be uniquely estimated
from a given set of experimental observation. In this context observabil-
ity/identifiability of a constrained model structure are defined as the possi-
bility to reconstruct the state of the system and to uniquely determine the
unknown constant parameters of the system from observing its input-output
behavior, respectively. Because the unknown parameters can be considered
as additional system states with time derivative zero, identifiability can be
seen as a special case of observability. Intuitively, the ability to distinguish
between each state variable from its neighboring points on the basis of ob-
servations is constitutive to ensure (local) observability, and observability
problem concerns with finding such a criteria. The time evolution of the
system (3.1) for a given u is fixed once the initial conditions x0 are known.
Thus (local) observability/identifiability analysis of the system results in
studying the (local) injectivity of the output function y with respect to the
parameters.
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3.2.1 A Priori Observability/Identifiability
Under the ideal conditions of error-free model structure and noise-free
data, a priori observability/identifiability analysis is a theoretical frame-
work to answer the question, whether the planned measurements will con-
tain enough information for the estimation of unknown parameters. This
analysis takes place before the estimation process and it is essential that the
input and measurement times can be chosen at will, and thus are structural
properties. A property is said to be structural (or generic) if it is true for
almost any value of parameters except a thin set of zero measure.
In the following, we consider the case where the inputs u are constant
and hence can be interpreted as additional parameters of the system
x˙(t) = f(x(t)), with x(t0) = x0 (3.28)
y(t) = h(x(t)) . (3.29)
Here, it is assumed that f : D → Rn and h : D → R are real analytic
functions, and the output y = y(t,x0) is viewed as a function of the ini-
tial condition x0. Systems of the form (3.28)-(3.29) are a valid description
for many biological processes under constant measurement conditions and
represent a sufficient framework for the type of models and experiments con-
sidered in this thesis.
The most natural definition of observability is the following.
Definition 2. Let U ⊆ D. Assume that for any initial conditions x0,x1 ∈ U
the corresponding solutions x0(t),x1(t) for t ∈ [t0, t1], t1 > t0 both lie in U .
Then, if
h(x0(t)) 6= h(x1(t))
for some t ∈ [t0, t1], then x0,x1 are said to be U-distinguishable.
We denote by I(x0,U) all points in U that are not U-distinguishable from
x0. The system (3.28)-(3.29) is said to be locally observable at x0 ∈ D if
for every open neighborhood U of x0, I(x0,U) = x0.
If U is equal to D, the system is said to be observable at x0 ∈ D. Notice,
however, if (3.28)-(3.29) has the observability property, it is still possible
that there is an arbitrary large interval of time in which two points of D can
not be distinguished from each other. The concept of local observability sets
a limit on time interval and thus is a stronger property than observability.
In practice, however, it is often sufficient to distinguish between neighboring
points. Therefore a weakened concept of local observability can be defined
as follows.
Definition 3. The system (3.28)-(3.29) is locally weakly observable at x0
if for every open neighborhood U of x0 there exist an open neighborhood V
of x0 contained in U , such that I(x0,U) ∩ V = x0.
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Intiutively, the referred system is locally weakly observable, if one can
instantaneously distinguish each point x0 ∈ D from its neighbors.
Recall h : D → R and f : D → Rn are real analytic functions, the latter is
called a vector field on D. Differentiation of h along the trajectories of the
system x˙(t) = f(x(t)) is formally done by Lie differentiation. The derivative
y˙ is given by
y˙ =
∂h
∂x
[f(x)] := Lfh(x) , (3.30)
where Lfh is called the Lie deriavative of h along f . By definition L0f = h
and higher order (iterated) Lie derivatives are defined by
L2f = Lf · Lfh(x), . . . , Lkf = Lf · Lk−1f h(x) .
Definition 4. The linear space over R of all iterated Lie derivatives at any
fixed x0
O(x0) = spanR{Lkfh(x0), k ≥ 0}
is called the observation space. The dimension of the observation space may
vary with x0 ∈ D, but if the iterated Lie derivatives Lkfh(x0), for k ≥ 0, are
linearly independent for all x0 ∈ D, then dim(O(x0)) = k for all x0 ∈ D.
Let dO = {dH,H ∈ O} denote the linear space spanned by the gradients
of the Lie derivatives. It is the dimension of dO which defines the locally
weak observability [40].
Theorem 3.2.1. The system (3.28)-(3.29) is locally weak observable for all
x in an open dense set of D if and only if
dimRxdO = n . (3.31)
As it is shown in [11] it is enough to calculate the first n−1 Lie derivatives
of the output function.
Theorem 3.2.2. Condition (3.31) is equivalent to the algebraic rank crite-
rion
rank J(x) := rank (dL0fh(x0)
T , . . . , dLn−1f h(x0)
T ) = n . (3.32)
The structural identifiability methods based on the differential algebraic
framework as described above exploit the characteristic set of the differential
ideal associated to the dynamic equations of the system. The construction of
this characteristic set ignores the algebraic set containing the steady state
initial states of the system (which is contained in the ”thin set”, where
the generic properties do not hold) and furthermore some of the structural
relationships among the initial states and the other parameters. It has
been shown, however, when started at this ”special” initial conditions, the
characteristic set of the ideal generated by the polynomials of the system
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may change, which leads to a failure of the identifiability test, unless a new
characteristic set is calculated to be taken as the basis [94].
In biological/physiological problems, however, identification experiments
are often performed on systems started from equilibrium initial conditions,
which may provide valuable information about some components of the ini-
tial condition vector and some constraints among the unknown constant
parameters. The physiological models considered in this thesis also fall into
this scope. In such a framework, one is usually concerned with testing hy-
potheses and need to focus on parameter values which are physiologically
meaningful, whereas the rest need not necessarily be identifiable [46].
Furthermore, the unique identifiability of the unknown parameters is
only a necessary condition for estimating them, but, it by no means guaran-
tees that such a solution can actually be found using real data. Thus some
form of a priori uniqueness analysis of the model may be an essential early
step in the design of parameter estimation problem [21].
Reid [88] has defined the term sensitivity identifiability, which is mo-
tivated by the fundamental association between system output parameter
sensitivities and system identification capability, and thus provides an addi-
tional tool to test a posteriori numerical identifability, from which we want
to make use here.
First, we will briefly summarize the mathematical framework of nonlinear
local optimization techniques and then we will introduce the methods for
sensitivity identifiability.
3.2.2 Nonlinear Least Squares Optimization
So far, we have focused exclusively on the ideal concept of error-free
measurements. In practical applications, however, the observations may be
corrupted by some measurement noise.
We consider the general nonlinear dynamical system (3.1) with a discrete
time observation process. Assume that the observations {Yi}Ni=1 are affected
by random deviations, which leads to a statistical model for the observation
process
Yi = h(x(ti),p) + σii for i = 1, . . . , N , (3.33)
where the fitted data {yi}Ni=1 are interpreted as the realizations of the ob-
served data {Yi}Ni=1. The sample points of N longitudinal measured process
output ti are ordered such that t0 ≤ t1 < t2 < · · · < tN < tmax and the ob-
servation function h(·) is again continuously differentiable in both variables
x and p. Here, we consider the case that all the experimental uncertainty
can be attributed to the dependent variables Yi and there are enough data
points to provide a good sampling of the experimental uncertainties (i.e.,
N > q + n). Further, the errors i are assumed to be random variables
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which can be described by a Gaussian distribution with zero mean and con-
stant variance σ20 <∞ , i.e.,
i ∼ N
(
0, σ20
)
(3.34)
and are uncorrelated (i.e., cov(i, j) = 0 whenever i 6= j).
For the estimation of unknown parameters, we use the ordinary least
squares method (OLS), which requires to minimize the weighted sum of the
squared errors loss function,
J(x0,p) =
N∑
i=0
(
Yi − h(x(ti),p)
σ0
)2
=
N∑
i=0
i (3.35)
with respect to initial conditions x0 and parameters p. Hence the errors are
Gaussian distributed according to (3.34), the probability density function
(pdf) of the error i is given by
p(εi) =
1
σ0
√
2pi
exp
(
−1
2
(
i
σ0
)2)
. (3.36)
Because the errors i are assumed to be independent, the maximum likeli-
hood function is equal to the product of the pdfs of each sample
N∏
i=0
p(i) , (3.37)
which has to be maximized to obtain parameters of being correct with the
highest probability. This is accomplished when J(x0,p) in Equation (3.35)
is minimized.
In most applications, the assumption of a normal distribution for the er-
rors is very reasonable and often at least approximatively valid in practice.
The central limit theorem states that the pdf of a sum of arbitrary dis-
tributed random variables approaches a Gaussian distribution as the num-
ber of random variables increases. Thus the assumption of a Gaussian dis-
tributed error can be justified and under these assumptions the least squares
estimate
argminx0,p
N∑
i=1
(Yi − h(x(ti),p)2 (3.38)
and the maximum likelihood estimate are equivalent [48,80]. Since the gra-
dient of the loss function J(ϑ) is nonlinear in the parameters ϑ = (x0,p), a
nonlinear optimization technique has to be applied to search for the optimal
parameters ϑopt.
In local optimization techniques an iterative algorithm is required. The
iterative search is started at one initial point and only the neighborhood of
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this point is examined. For nonlinear optimization problems, usually many
local optima exist and with local optimization algorithms one of them closest
to the initial point is found. A search of global character can be constructed
by restarting a local method from many different initial points and finally
choosing the best local solution. It is obvious that a good guess of the ini-
tial parameters will lead to fast convergence of the algorithm and a high
probability of converge to the best solution. In physiological modeling the
parameters usually represent physical variables or other interpretable quan-
tities for which enough prior knowledge is available to chose a reasonable
initial guess.
A natural procedure to find a minimum of a given loss function with
respect to the parameters is to evaluate this function and possibly its deriva-
tives for different parameter values ϑ(k). At each iteration k, a new param-
eter value can be computed from the past parameter values, the previous
loss function values, and possibly its derivatives
ϑ(k) = f
(
ϑ(j), J(ϑ(j)),
∂
∂ϑ(j)
J(ϑ(j))
)
with j = k − 1, k − 2, . . . , 0 .
(3.39)
Consequently, at each iteration the loss function and possibly its deriva-
tives have to be evaluated. If the whole data set is large, it is divided into
representative subsets to successively apply the optimization process (3.39).
In direct search algorithms, only the evaluation of the loss function is
used and no derivatives are required. Even if such methods are easy to imple-
ment, they are not reasonable to apply if the derivatives are available, since
they usually show slow convergence. Even if the derivatives are unavailable,
a powerful alternative method to direct search algorithms for the generation
of search directions is to apply a gradient-based method in connection with
finite difference techniques to compute the gradient numerically.
3.2.3 General Gradient Based Algorithms
In the following, we assume that the gradient g = ∂J(ϑ)∂ϑ of the loss func-
tion J(ϑ) with respect to the parameter vector ϑ can either be calculated
analytically or is approximated by finite difference techniques (see below).
The principle of all gradient-based algorithms is to modify the search
direction according to
ϑ(k) = ϑ(k−1) − µ(k−1) p(k−1) with p(k−1) = R(k−1) g(k−1) . (3.40)
Here, the gradient direction g(k−1) is modified by some direction matrix
R(k−1), p(k−1) is the modified gradient direction and µ(k−1) is the step size.
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The goal of the optimization is to obtain a decrease in the loss function
value in each iteration step, i.e., J(ϑ(k)) < J(ϑ(k−1)). This is the case for
positive definite direction matrices R(k−1). Different choices of the direc-
tion matrix and step size distinguish between existing algorithms such has
steepest descent, Newton, quasi-Newton, and conjugate gradient methods.
Finite Difference Techniques
If the derivation of an analytical expression for the gradient is not pos-
sible or it is computationally too expensive to evaluate, finite difference
techniques can be used for numerical calculation of the gradient.
The gradient component i at point ϑ can be approximated by the dif-
ference quotient
g
i
(ϑ) ≈ J(ϑ+ ∆ϑi)− J(ϑ)
∆ϑi
, (3.41)
where ∆ϑi is a ”small step” into the ith coordinate axis direction. This
means that for approximation of the full gradient g at point ϑ the ex-
pression (3.41) has to be evaluated for all search space directions and thus
the computational effort required for gradient determination is equal to the
number of parameters q + n.
In principle, it is also possible to approximate the Hessian by applying
finite difference techniques to the gradient. The ith column hi of the Hessian
H can be calculated by
hi ≈
g(ϑ+ ∆ϑi)− g(ϑ)
∆ϑi
. (3.42)
For this calculation, however, the gradients have to be available analytically.
Quasi-Newton Methods
In Newton’s method the direction matrix R in (3.40) is chosen as the
inverse of the Hessian
(
H(k−1)
)−1
of the loss function at the point ϑ(k−1),
ϑ(k) = ϑ(k−1) − µ(k−1)
(
H(k−1)
)−1
g(k−1) . (3.43)
Hence, to apply the Newton’s method all second order derivatives of the
loss function have to be known analytically or estimated by finite difference
techniques, which requires O(q + n) gradient calculations. The decrease in
the loss function value can only be achieved for a positive definite Hessian
H(k−1). In the neighborhood of the optimum this condition is always ful-
filled, however, it cannot be necessarily expected to hold for the initial point
ϑ(0) and the first iterations.
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To avoid this problem a modified Newton method is often applied in
which the Hessian is approximated by a matrix Hˆ
(k−1)
that is guaranteed
to be positive definite but is close to H(k−1). The approach of approximating
the inverse Hessian has the advantage that no matrix inversion has to be
performed in (3.43). The approximation of the Hessian is usually started in
the opposite gradient direction and is defined for further iteration steps as
Hˆ
(k)
= Hˆ
(k−1)
+Q(k−1) , (3.44)
where all quasi-Newton methods differ by the kind of formula for Q [80]. The
Gauss-Newton method is the nonlinear least squares version of the general
Newton method in (3.43).
3.2.4 Constrained Nonlinear Optimization
Constraints emerge from available knowledge or restrictions about the
parameters. A general constrained nonlinear optimization problem may in-
clude inequality and equality constraints or constraints regarding the bounded
parameters by their minimum and maximum value. Thus, in the framework
of a nonlinear least squares problem the estimation problem (3.38) is subject
to the constraints
gi(ϑ) ≤ 0, i = 1, . . . ,m, (3.45)
hj(ϑ) = 0, j = 1, . . . , l. (3.46)
This leads to the following Lagrangian, which is defined as the sum of the
unconstrained loss function and the weighted constraints:
L(ϑ, λ) = J(ϑ) +
m∑
i=1
λi gi(ϑ) +
l∑
j=1
λj+m hj(ϑ) . (3.47)
The Kuhn-Tucker equations give the following necessary (and for convex
problems also sufficient) conditions for the optimality [112]
ϑopt is feasible, i.e., it meets the constraints, (3.48)
λi gi(ϑopt) = 0, i = 1, . . . ,m λi ≥ 0 , (3.49)
∂J(ϑopt)
∂ϑ
+
m∑
i=1
λi
∂gi(ϑopt)
∂ϑ
+
l∑
j=1
λj+m
∂hj(ϑopt)
∂ϑ
= 0 . (3.50)
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The equation (3.49) describes the canceling of the gradients between the
loss function and the active constraints at the solution point. For the gradi-
ents to be canceled, Lagrange multipliers (λi, i = 1, . . . ,m) are necessary to
balance the deviations in magnitude of the loss function and constraint gra-
dients. Only active constraints are included in this canceling operation, thus,
the Lagrange multipliers of those inequality constraints with gi(ϑopt) < 0
are zero. The Equation (3.50) requires the first order derivative of the La-
grangian to be equal to zero.
Constrained quasi-Newton methods guarantee superlinear convergence
by accumulating second order information regarding the Kuhn-Tucker equa-
tions using a quasi-Newton updating procedure. These methods are com-
monly referred to as Sequential Quadratic Programming (SQP) methods and
are included in many optimization packages.
We used the Matlab routine fmincon to solve the constrained nonlin-
ear optimization problem [70]. The function fmincon uses a Sequential
Quadratic Programming method to solve the subproblem at each iteration.
At the begin of each iteration the gradient of the objective function at the
current point is evaluated (using finite difference equations), and also an es-
timate of the Hessian of the Lagrangian is updated to choose a new location
to start the next iteration. The successive improvement of the estimates,
which is subject to a specialized tolerance, leads to the optimization result
after a number of iterations. The simulation of the system trajectory is done
by the ODE solver ode15s.
3.2.5 A Posteriori Identifiability
To test a posteriori the local identifiability of parameters ϑ = (x0,p)
in the following the concept of sensitivity identifiability is outlined. For
this, we denote by ϑˆ = ϑopt the vector of estimated parameter, obtained by
minimizing the nonlinear least squares functional
J(ϑ) =| Y − h(ϑ) |2 (3.51)
as described above. To obtain a local minima, the following two conditions
have to be satisfied. First
∇ϑJ(ϑ) |ϑ=ϑˆ= −2χn(ϑˆ)T
(
Y − h(ϑˆ)
)
= 0 , (3.52)
where χN (ϑˆ) is called the output sensitivity matrix of the system and its
i-th row is equal to ∇ϑh(ti, ϑˆ), i.e.,
χNij (ϑ0) =
∂h(ti,ϑ)
∂ϑj
|ϑ=ϑ0 1 ≤ i ≤ N, 1 ≤ j ≤ q + n . (3.53)
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And second, the Hessian
∇2J(ϑ) |ϑ=ϑˆ= 2χN (ϑˆ)Tχn(ϑˆ)−G(ϑˆ) (3.54)
with
G(ϑˆ) = 2
N∑
i=1
(
Yi − h(ti, ϑˆ)
)
∇2ϑh(ti,ϑ) |ϑ=ϑˆ (3.55)
is positive definite. Suppose the model output h is well approximated by its
linear Taylor expansion around ϑˆ, i.e.,
∆h ≈ χN (ϑˆ)∆ϑ , (3.56)
with ∆h = h(ϑ) − h(ϑˆ) and ∆ϑ = ϑ − ϑˆ. To obtain a unique solution of
(3.56) for ∆ϑ, nonsingularity of the sensitivity matrix χN (ϑˆ) is required.
This lead us to the following necessary and sufficient condition for sensitivity
identifiability of the structured system [21,46].
Corollary 3.2.1. A structure is called sensitivity identifiable, if a uniquely
local solution of Equation (3.56) for ∆ϑ can be obtained. This is the case if
and only if the matrix χN (ϑˆ) has full rank.
In this linearized case, G(ϑˆ) = 0 in Equation (3.54), χN (ϑˆ)TχN (ϑˆ)
is positive definite and hence invertible. Thus an equivalent condition to
Corollary (3.2.1) can be formulated.
Corollary 3.2.2. A uniquely local solution of Equation (3.56) for ∆ϑ can
be obtained if and only if the matrix χN (ϑˆ)TχN (ϑˆ) is invertible, i.e.,
det
(
χN (ϑˆ)TχN (ϑˆ)
)
6= 0 . (3.57)
For a given ϑ = ϑˆ, the sensitivity functions are defined by
Spk(t) =
∂x
∂pk
, k = 1, . . . , q (3.58)
Kx0l(t) =
∂x
∂x0l
, l = 1, . . . , n , (3.59)
where x0l is the lth component of the initial condition x0. The vector func-
tions S = (Sp1 , . . . , Spq) and K = (Kx01 , . . . ,Kx0n) can be obtained by
simultaneously solving the following system of sensitivity differential equa-
tions
S˙(t) =
∂f
∂x
S(t) +
∂f
∂p
, with S(t0) = On×q , (3.60)
K˙(t) =
∂f
∂x
K(t), with K(t0) = In×n , (3.61)
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where O and I denote the zero and identity matrices, ∂f∂x and
∂f
∂p are the
Jacobians with respect to x and p, respectively.
Because the parameters p may have different units, it is convenient to
use the so called normalized sensitivity coefficients px
∂x
∂p to make them com-
parable [109].
By investigating the sensitivity function matrix for observations {Yi}Ni=1,
the N×(q+n) output sensitivity matrix χN (ϑˆ) consists of the corresponding
columns containing only the time derivatives of the output function with
respect to parameter p and initial conditions x0
χN (ϑˆ) =

∂h(t1)
∂p1
· · · ∂h(t1)∂pq
∂h(t1)
∂x01
· · · ∂h(t1)∂x0n
...
. . .
...
...
. . .
...
∂h(tN )
∂p1
· · · ∂h(tN )∂pq
∂h(tN )
∂x01
· · · ∂h(tN )∂x0n
 . (3.62)
Remark 6. To allow for equality constraints in the sensitivity analysis, the
sensitivity matrix χN is extended by the Jacobian Z associated with the
equality constraints in (3.3). Assuming a number of M equality constraints,
the extended (N +M)× (q + n) sensitivity matrix reads
ΩN (ϑˆ) := (χN Z). (3.63)
Remark 7. Notice that distinguishability underlies also the concept of sen-
sitivity identifiability. If a parameter does not influence the observations,
it can also not be distinguished from any other parameter by observing the
output process and the sensitivities of the output to that parameter is zero.
Also, if there is a linear dependence between any of the parameters, there
will be also one between the sensitivities of the output to these parameters.
In both of these cases, the sensitivity matrix will be rank deficient, meaning
that the parameter are not uniquely local identifiable.
3.2.6 Qualitative Analysis of Parameter Estimates
We make the standard statistical assumption that there exists a ”true”
value ϑ0 of the parameter vector ϑ. Thus, the estimated parameter values
ϑˆ can be interpreted as realizations of this random variable ϑ0 and the
accuracy of the parameter estimates ultimately depends on the statistical
properties of ϑ0. In order to qualitatively analyze the estimates, we use a
standard error approach [13, 19]. From the asymptotic theory of statistical
analysis, it can be shown that as N → ∞, ϑˆ is approximately distributed
according to a multivariate normal distribution, i.e.,
ϑˆ ∼ Nn+q(ϑ0,Σ0) , (3.64)
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where the covariance matrix Σ0 is given by
Σ0 = σ20
(
χN (ϑ0)TχN (ϑ0)
)−1
. (3.65)
The covariance matrix Σ0 is used to formulate the standard errors for the
estimates ϑˆ. These are given by
SEk(ϑ0) =
√
σ20 (χN (ϑ0)TχN (ϑ0))
−1
kk , k = 1, . . . , q + n . (3.66)
Because ϑ0 is unknown, it is replaced by ϑˆ when calculating approximations
for (3.66). Moreover, the unknown constant error variance σ20 is approxi-
mated by σˆ20 which is calculated as
σˆ20 =
1
N − (q + n) | Y − h(ϑˆ) |
2 . (3.67)
This lead us to the approximated covariance matrix
Σˆ0 = σˆ20
(
χN (ϑˆ)TχN (ϑˆ)
)−1
, (3.68)
and standard errors
SEk(ϑˆ) =
√
(Σˆ0)kk , k = 1, . . . , q + n , (3.69)
which are used to quantify uncertainty in the estimation.
For ϑˆ we define a vector of coefficients of variation v(ϑˆ) ∈ Rq+n such
that for each k = 1, . . . , q + n ,
vk(ϑˆ) =
√
(Σˆ0)kk
ϑˆk
. (3.70)
The components of the vector v(ϑˆ) are the dimensionless ratios of each
standard error for a parameter to the corresponding nominal parameter
value.
Next, we define
α(ϑˆ) =| v(ϑˆ) | , (3.71)
which is called the parameter selection score, and note that α(ϑˆ) near zero
indicates lower uncertainty possibilities in the estimation while large values
of α(ϑˆ) suggest that one could expect to find a wide uncertainty in at least
some of the estimates [19].
Furthermore, a set of parameters may be identifiable but the relevant
matrix χTχ may be near singular, which results in a poor estimability.
The correlation coefficients between the components of ϑˆ reveals direct in-
formation on our ability to estimate each parameter and on the effect of
parametrization of the model.
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The correlation coefficients between two components of ϑˆ is given by
corr(ϑˆk, ϑˆl) =
cov(ϑˆk, ϑˆl)
σϑkσϑl
. (3.72)
Using the definition of covariance matrix, we have that cov(ϑˆk, ϑˆl) is simply
the (k, l)-th element of Σˆ0 and the standard derivations σϑk and σϑl are the
square roots of the (k, k)-th and (l, l)-th diagonal entries.
Chapter 4
Modeling Isoprene
Isoprene is one of the most abundant endogenous volatile organic com-
pounds (VOCs) contained in human breath and is considered to be a poten-
tially useful biomarker for diagnostic and monitoring purposes as described
in Section 1.2. However, neither the exact biochemical origin of isoprene nor
its physiological role are understood in sufficient depth, thus hindering the
validation of breath isoprene tests in clinical routine.
Exhaled isoprene concentrations are reported to change under different
clinical and physiological conditions, especially in response to enhanced car-
diovascular and respiratory activity. Physiologically, this effect could be
attributed to functional changes in the lung such as redistribution of venti-
lation and/or perfusion, recruitment and distension of pulmonary capillaries
or changes in mixed venous concentration due to depletion of an isoprene
buffer tissue. Investigating isoprene exhalation kinetics under dynamical
exercise helps to gather the relevant experimental information for under-
standing the gas exchange phenomena associated with this important VOC.
In the following we will investigate several models concerning isoprene
exchange mechanism under physical exercise starting with a five compart-
ment model developed by Filser et al. [30]. The modeling focus in the present
work lies in the global dynamics of the averaged compartmental concentra-
tions, therefore, no attention has been paid to any transport delays between
tissues, heart and lung. Such effects can be taken into account by consider-
ing delay differential equations. The interested reader may refer to Batzel
et al. [16] for modeling examples of cardiovascular and respiratory systems
with time delay and to Haddad et al. [37] for a qualitative analysis of such
compartmental dynamical systems.
The following basic assumptions apply to the models considered in the
scope of this thesis.
• Uptake occurs only via inhalation whereas excretion occurs via exha-
lation and metabolic elimination.
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• The lung compartment is assumed to be ventilated by a continuous
unidirectional stream of gas. Ventilation is tidal in nature and concen-
trations of gases in exhaled breath are subject to fluctuations through-
out the breathing cycle. The dynamics of gases in inhalation and
exhalation phase can be captured by considering two separate mass
balance systems for each of them (see, e.g., [68]). Such a formulation
may be indispensable to describe processes which take place within
one respiratory circle. We are interested in mid- to long term kinetics
of compounds and extract the end-tidal breathing volume for anal-
ysis though. Additionally, the analysis delay of apprr. 10 s entails
the mixture of about three subsequent end-tidal breath phases in the
sample line during normal breathing. Thus, we study the averaged
breath concentrations and consider the assumption of continuous and
unidirectional ventilation to be appropriate for our purposes.
We also assume that the left and right cardiac output are equal and
continuous.
• Diffusion between blood in the capillaries and air in the alveoli is
thought to be a very rapid process. Therefore, an instantaneous equi-
libration between alveolar air and end-capillary (arterial) blood is as-
sumed. Due to its low affinity for blood and its small molecular size,
this instantaneous diffusion equilibrium is a reasonable assumption for
isoprene. It is likely to hold also under moderate, sub-anaerobic exer-
cise conditions [115]. Additionally, since isoprene does not form chem-
ical bindings with blood, Henry’s Law (A.9) applies. Consequently,
the proportional relationship between arterial concentration Ca and
mixed alveolar concentration CA is expressed by
Ca = λb:airCA . (4.1)
Here, λb:air denotes the isoprene-specific blood:gas partition coefficient
as introduced in Section 1.2.
• Venous equilibrium as described in Section 2.3 is assumed. Accord-
ingly, the relationship between the single compartment concentration
( Ci) and eﬄuent venous blood (Ci,v) is described by
Ci,v = λb:iCi , (4.2)
where λb:i is the partition coefficient between blood and and compart-
ment.
• In metabolic active compartments, the rate of production is assumed
to be constant, whereas metabolic elimination is described either by
Michaelis-Menten kinetics or by linear kinetics as described in Section
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2.3. For experiments carried out using a closed exposure system, a
saturable Michaelis-Menten kinetics may be appropriate to describe
the metabolic elimination. For normal conditions with low or negligi-
ble concentrations of isoprene in the atmosphere, however, saturable
kinetics can be approximated by linear kinetics since it has been shown
that up to 30 ppm (parts per million) of isoprene in the atmosphere
the metabolic rate is proportional to this concentration [30].
4.1 A Five Compartment Physiological Toxicoki-
netic Model
The toxicologic effect of inhaled isoprene has thrilled the first investiga-
tions of its exchange mechanisms. Filser et al. [30] have derived a physio-
logical five compartment model, which includes the lung, fat, muscle com-
partments, liver and richly perfused tissue (RPT) compartment (containing
brain, intestines, kidney and spleen). Inhalation studies have been carried
out to investigate the carcinogenic effects of isoprene and to estimate its tis-
sue and organ concentrations, ultimate reactive metabolites, and, metaboli-
cally produced epoxides. Liver and RPT compartment are specified as sites
of metabolism based on the knowledge described in Section 1.2 and on in
vivo gas exchange experiments in a closed exposure system performed in [30].
A sketch of the model structure is given in Figure 4.1.
In the mentioned article besides the in vivo determination of the metabolic
parameters for isoprene (given in Table 4.1), in vitro studies were performed
using a headspace technique to determine blood:tissue and blood:air parti-
tion coefficients (given in Table B.1). Additionally, the constant production
rate klivpr was estimated from the isoprene concentrations in the headspace
of the closed exposure system.
Metabolic parameters Abbreviation Man Unit
Maximum metabolic rate in liver V livmax 1690 (µmol/h)/indiv.
Maximum metabolic rate in RPT V rptmax 188 (µmol/h)/indiv.
Michaelis Menten constant Km 2 µmol/l
Table 4.1 – Metabolic parameters of isoprene obtained in mice and rats,
extrapolated to humans based on body weight to a power of 3/4. Vmax is
splitted assigning 90% to the liver and 10% to the richly perfused tissue group.
The Michaelis constant (Km) is assumed to be identical in rats and humans
and the same value for Km is given in both compartments [30].
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Fig. 2 Sketch of the model structure developed by Filser.
Figure 4.1 – The model sketch of the five compartment model developed by
Filser et al. [30]. The body is subdivided into five distinct functional units:
alveolar/end-capillary compartment (gas exchange), RPT (metabolic elimina-
tion) includes brain, intestine, kidney, spleen and other organs, fat compart-
ment (storage), muscle compartment (storage), and liver compartment (pro-
duction and metabolic elimination). Dashed borders indicate diffusion equi-
librium. A closed exposure atmosphere was used to determine the metabolic
parameters.
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The lung was assumed to be a single homogeneous compartment with a
diffusion equilibrium between alveolar gas and end-capillary blood. Under
these assumptions the model is described by the following set of differential
equations.
Alveolar compartment,
V˜A
dCA(t)
dt
= V˙A(t) (CI − CA(t)) + Q˙c(t) (Cv¯(t)− CA(t)λb:air) , (4.3)
RPT compartment,
V˜rpt
dCrpt(t)
dt
= qrpt(t)Q˙c(t) (Ca(t)− λb:rptCrpt(t))
− krptmetλb:rptCrpt(t) , (4.4)
fat compartment,
V˜fat
dCfat(t)
dt
= qfat(t)Q˙c(t) (Ca(t)− λb:fatCfat(t)) , (4.5)
muscle compartment,
V˜mus
dCmus(t)
dt
= qmus(t)Q˙c(t) (Ca(t)− λb:musCmus(t)) , (4.6)
and, liver compartment,
V˜liv
dCliv(t)
dt
= qliv(t)Q˙c(t) (Ca(t)− λb:livCliv(t))
+ klivpr − klivmetλb:livCliv(t) . (4.7)
In view of the diffusion equilibria, the compartment capacities are gov-
erned by the effective volumes
V˜A := VA + Vc′λb:air ,
V˜rpt := Vrpt + Vrpt,bλb:rpt ,
V˜fat := Vfat + Vfat,bλb:fat ,
V˜mus := Vmus + Vmus,bλb:mus ,
V˜liv := Vliv + Vliv,bλb:liv .
The mixed venous concentration is given by the following algebraic equa-
tion as the weighted average of the compartmental venous concentrations
Cv¯(t) := qrpt(t)λb:rptCrpt(t) + qfat(t)λb:fatCfat(t) (4.8)
+ qmus(t)λb:musCmus(t) + qliv(t)λb:livCliv(t) .
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The above five compartment model was only investigated for steady state
conditions, where the constant blood flow fractions to the systemic compart-
ments were determined proportional to the cardiac output. To capture the
redistribution of the systemic perfusion during ergometer exercise, we ap-
proximate the fractional blood flows through the systemic compartments by
the following equations.
qrpt(Q˙c) := qrestrpt − (qrestrpt − qminrpt )×
(
1− exp (−τrpt max{0, Q˙c − Q˙
rest
c
Q˙restc
})),
qliv(Q˙c) := qrestliv + (q
rest
liv − qminliv )×
(
1− exp (−τliv max{0, Q˙c − Q˙
rest
c
Q˙restc
})),
qfat(Q˙c) := constant ,
qmus(Q˙c) := 1−
(
qrpt(Q˙c) + qfat(Q˙c) + qliv(Q˙c)
)
.
Here, qi ∈ (0, 1) designates the fractional blood flow to the compartment
i and τrpt, τliv are positive constants. These relationships are justified by
exponential fitting of the perfusion data given in [77], and, τrpt, τliv are es-
timated to be 1.18 and 1.08 respectively. Reference values for the indicated
fractional blood flows can be found in Table B.2, where fractional blood
flows for rest conditions qresti and for maximal workload (q
min
rpt , q
min
liv ) corre-
spond the values for 0 W and 150 W, respectively.
When investigating the exhalation dynamics of isoprene under ergome-
ter workloads, we are interested in effects of physiological and metabolic
parameters on exhaled concentrations. The five compartment model de-
scribed above fails to capture the observed isoprene time courses during
ergometer experiments described in Section 1.3.
As it has been mentioned previously, physical activity causes distinctive
changes in exhaled isoprene profile. End-tidal isoprene abruptly increases
at the onset of exercise, e.g., at 75 W, usually by a factor of about 3 − 4
compared with steady state value during rest (compare Figure 1.3). This
phase is followed by a gradual decline and the development of a new steady
state after about 15 min of pedaling [53]. This abrupt peak shaped response
of isoprene has assumed to be a result of changes in hemodynamics or in
pulmonary function rather than comparatively slow mechanisms of endoge-
nous synthesis. Indeed, a constant source of isoprene has been suggested
during sleep and during exercise [50].
Isoprene has a small blood:gas partition coefficient which implies its low
affinity for blood and makes the human body an inefficient source for iso-
prene. According to the basic model of inert gas exchange in the lung
(cf. Equation (1.4)), low soluble gases react highly sensitive even to small
changes in ventilation or pulmonary perfusion. More specifically, Farhi’s
equation (1.4) predicts that, other factors being equal, increasing/decreasing
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alveolar ventilation will result in decreased/increased exhaled breath concen-
trations, whereas the relationship between breath concentrations and cardiac
output is monotonic and reflects the dependence on supply. Based on sim-
ilar reasoning, Karl et al. [50] suggested a physiological two compartment
model describing the breath isoprene time courses during exercise on an er-
gometer. We start by investigating this model as it seems to explain the
observed concentration courses of isoprene during exercise on an ergometer
and thus is widely accepted as ”standard model”.
4.2 A Serial Model of the Lung
The aforementioned physiological model consists of two compartments.
The first compartment contains the blood-lung circuit where the source of
isoprene is situated without precise specification of its exact location. The
production rate of isoprene is assumed to be constant. The second compart-
ment contains the breath air-lung circuit where isoprene exchange occurs
between the environment and alveolar air. The lung is assumed to consist
of adjacent segments of lung volume, so that blood passes several alveoli in
series with concentration declining from the venous to arterial side. In each
differential volume of the lung gas exchange between capillary blood and
arterial air is by passive diffusion. The model sketch from the original work
of Karl et al [50] is given below.
there exists near equilibrium between the blood iso-
prene concentration and the breath isoprene concen-
tration. This is due to Henry’s law partitioning of blood
gases with alveolar air. An average blood isoprene
concentration thus is correlated to an average breath
isoprene concentration over the whole lung volume.
With this model, it becomes obvious that, with a given
isoprene production rate, the average breath isoprene
concentration is governed by the rates at which blood is
pumped through the lungs (heartbeat rate) and breath
air is exchanged (breath rate).
In a typical situation of an adult person being at slow
movement close to rest, the breath rate volume (Vbr) is
￿7.5 l/min, and the heart pump volume is￿5 l/min. As
the Henry’s law constant for isoprene is extremely low
at 0.029 M/atm (water-air at 310K; Ref. 14), only a very
small amount of isoprene is dissolved in the human
body and thus also in the blood (￿2 ￿ 10￿4 mg/l at an
average concentration of 100 ppb). When isoprene-free
air is breathed into the lungs, it becomes enriched with
isoprene dissolved in the blood, causing a marked re-
duction in the blood isoprene concentration within the
lungs and, therefore, causing a substantial drop in the
isoprene concentration between the venous and arte-
rial blood of ￿85%. This drop is calculated in the
following way.
Under stationary conditions, the venous blood enter-
ing the lungs has an isoprene concentration CV0, and
the arterial blood leaving the lungs has a concentration
CA0. Within the lungs, we can connect to each differ-
ential volume (using the compartment model) a con-
centration CD, and, assuming an exponential drop of
the isoprene concentration along the axis of the differ-
ential volumes, we obtain
CD(V) ￿ CV0 ￿ exp￿￿ VbrH ￿ R ￿ T ￿ V0 ￿ VHBV￿ (3)
where V is volume, H is Henry’s law constant, T is
temperature, V0 is the total volume of the lungs, and
HBV is the heartbeat volume. The concentration CD is
changing from one differential volume of the lung to
the other.
Before entering the lungs at V ￿ 0, the isoprene
concentration in the venous blood is CV0 ￿ CD(0), and,
at the exit, at V0, the arterial blood has the concentra-
tion CD(V0) ￿ CA0, with both being connected by the
relation
CA0￿ CV0 ￿ exp￿￿ 1HRT ￿ VbrHBV￿ (4)
Using the above-mentioned values, Vbr ￿ 7.5 l/min
and HBV ￿ 5 l/min for a person under normal condi-
tions, as well as the Henry’s law constant for isoprene
(0.029 M/atm), Eq. 4 yields a difference between the
concentrations of isoprene in the arterial and venous
blood of ￿85%.
From Eq. 4 we also see that, for compounds like
methanol with large Henry’s law constants (i.e., ￿100
M/atm), the exponential factor approaches unity, indi-
cating that there is no concentration gradient within
the lungs.
Fig. 2. A 2-compartment, gas-exchange model for the
dynamics of exhaled isoprene. In this model, isoprene
dissolved in venous blood rapidly partitions into the
alveolar air spaces of the lung and is exhaled with
expired air. The degree of blood-to-air partitioning of
isoprene is very sensitive to heart rate, and, as shown
in the center of the diagram (lung with sequential
alveoli), at elevated heart rate there is 1) a much
shallower isoprene concentration gradient and 2) a re-
sulting increase in isoprene in arterial blood exiting the
lungs. With increases in both heart rate and breath
rate, more efficient partitioning of isoprene to breath
air is restored. Other details of the model are described
in the text. Cblood, blood isoprene concentration; rvt,
Breath rate volume.
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Figur 4.2 – The model sketch of the two compartment model developed by
Karl et. al. [50].
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Recall that the gas exchange in one alveolus is described by Equation
(2.6). In steady state (independent of time), the Equation (2.6) reduces to
the first-order, linear ordinary differential equation
d
dv
Cb(v) =
V˙A
Q˙cV ′D
(
CI − Cb(v)
λb:air
)
. (4.9)
We suppose that the blood concentration at the inflow is fixed at Cb(0). In
steady state, the concentration at each position v is given by the solution of
the Equation (4.9)
Cb(v) = CIλb:air + exp
(
− v
λb:air
· V˙A
Q˙cV ′D
)
(Cb(0)− CIλb:air) . (4.10)
(Compare [50] Equation (3) for CI = 0).
Now we take account of the assumption that the lung consists of several
alveoli connected in series. Let VL denote the whole lung volume. If the in-
spired concentration of the substance equals zero (CI = 0), Equation (4.10)
extended to the whole lung volume (i.e., evaluated at VL) yields
Ca = Cv¯ exp
(
− 1
λb:air
· V˙A
Q˙c
)
, (4.11)
where the blood entering the lung has the mixed venous concentration Cv¯
and the blood leaving the lungs has the arterial concentration Ca. (Compare
[50] Equation (4)).
To get the blood concentration in the lung, we average the blood con-
centrations in each alveolus over the lung volumina VL with respect to v:
C¯b =
1
VL
∫ VL
0
Cb(v)dv = Cv¯ λb:air
Q˙c
V˙A
(
1− exp
(
− 1
λb:air
· V˙A
Q˙c
))
. (4.12)
(Compare [50] Equation (5)).
Because of the large alveolar surface area compared to alveolar volume
equilibrium between capillary blood and alveolar gas in each partial lung
volume is assumed. Over the whole lung volume, the correlation between
the average blood isoprene concentration and the average breath isoprene
concentration is expressed by the following equation according to Henry’s
Law (A.9).
CA =
C¯b
λb:air
. (4.13)
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By considering a single homogenous body compartment with a constant
production rate the mass balance equation for the blood-lung compartment
is given by
d
dt
Cbody(t)V˜body = Q˙c(t) (Ca(t)− Cv¯(t)) + kpr . (4.14)
We take the venous equilibrium assumption into account and state that
the mixed venous blood concentration and the concentration in the tissue
compartment are proportional with proportionality constant λb:body, which
denotes the blood:body partition coefficient, i.e.,
Cv¯ = λb:bodyCbody . (4.15)
Finally, substituting Equations (4.15) and (4.11) into Equation (4.14) yields
d
dt
Cv¯(t) =
λb:body
V˜body
(
Q˙c(t)Cv¯(t)
(
exp
(
− V˙A(t)
λb:airQ˙c(t)
)
− 1
)
+ kpr
)
.
(4.16)
For steady state conditions, and when CA is known, the production rate
can be derived from the model equations (4.11)-(4.14). Simulation results for
exercise conditions performed with real-time measurements of physiological
data show that the volume of the body compartment and its blood:tissue
partition coefficient do not affect the height of the initial peak in exhaled
concentration, but the following decrease to a new steady state.
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Figure 4.3 – Isoprene exhalation profile during one step exercise: 5 min resting
- 15 min exercise (75 W) - 10 min resting (green line) compared to the serial
model described above with the same data (black). For the simulation V˜A = 5
l, V˜body = 51.55 l and λb:body = 0.11 are assumed.
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According to this model, the initial peak shaped behavior of exhaled
isoprene at the onset of exercise can only be explained by markedly delayed
increase in alveolar ventilation with respect to the pulmonary blood flow.
According to the explanation in [50] as soon as exercise starts the pulmonary
blood flow increases (which is proportional to the heartbeat frequency) re-
sulting in a higher breath isoprene concentration because during this initial
period of exercise the breathing rate has not yet changed. As the source of
isoprene stays constant, the enhanced rate of evaporation leads to a decline
in the blood isoprene concentration and thus of the evaporation rate. A
few minutes after the start of exercise, the breath rate increases, leading to
an enhanced dilution of isoprene, again resulting in a decline in the breath
isoprene concentration to a new, lower steady-state level. This effects are
reversed at the end of the exercise where breath rate and heart rate again
reach values similar to those before the start of exercise, and therefore also
the concentration of isoprene in the breath becomes similar to that before
the start of experiment. The breath rate during the experiment has not been
measured continuously. In fact, as stated in Section 1.2 the assumption of a
delayed response of alveolar ventilation to dynamical exercise with respect
to pulmonary blood flow is physiologically not justified and it also contra-
dicts experimental evidence (see e.g., [53]). Figure 4.3 shows real-time data
obtained during a one-step exercise at 75 W compared to the model output
with the same data.
Moreover, the assumption of alveoli connected in series is questionable.
A more common view of the actual geometry of the lung is that alveoli are
connected in parallel [43, 114, 118]. The blood leaving the right heart is
subdivided many times by the branching pulmonary arterial tree before it
reaches the alveoli. After passing through the alveoli, it is collected by the
pulmonary veins. The alveolar capillaries are therefore connected in par-
allel in the sense that the pulmonary blood flow is the sum of the blood
flows of the individual alveoli. In a similar way, air entering the trachea
is subdivided many times by the bronchial tree before it reaches the alve-
oli, and the total alveolar ventilation is the sum of the individual alveolar
ventilations [43]. However, due to several normal factors, there exist re-
gional differences in gas exchange down the normal lung causing an uneven
distribution of ventilation-perfusion (V˙A/Q˙c) ratios (see Section 1.4). The
influence of V˙A/Q˙c distribution on the gas exchange between alveolar air
and arterial blood can be described by a multi compartment model having
a range of V˙A/Q˙c values from zero to infinity. In such a model shunt is
represented by not ventilated alveoli (V˙A/Q˙c = 0) and alveolar dead space
is represented by not perfused alveoli (V˙A/Q˙c ≈ ∞). As V˙A/Q˙c− ratios
increase from zero and decrease from infinity, gas exchange efficiency in-
creases until the optimum ratio of about 0.86 is reached. In real life, there
is a spread of V˙A/Q˙c values throughout the lung around this ”ideal” value.
The larger the spread, the greater is the inefficiency of gas exchange.
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In the following we will consider a three compartment lung model, with
compartments representing homogenous groups of alveoli that are connected
in parallel.
4.3 A Parallel Model of the Lung
We consider each alveolus as a homogenous well-mixed compartment
and that as blood passes through the alveolus, it achieves equilibrium with
alveolar air. If we number the alveoli using an index i, i = 1, . . . , n, and de-
note the mean alveolar concentration in alveolus i by CA,i, the mass balance
equation derived from Equation 2.7 for each alveolus reads
V˜A,i
d
dt
CA,i(t) = qiQ˙c(t) (Cv¯(t)− CA,i(t)λb:air)
+ viV˙A(t) (CI(t)− CA,i(t)) . (4.17)
Here fractional blood and air flows to compartment i are denoted by qi
and vi, respectively. The effective volume of alveoli i again is defined by
V˜A,i := VA,i + Vi,bλb:air, where VA,i is the volume of gaseous phase, and Vi,b
is the capillary blood volume. In steady state the solution of (4.17) are
CA,i =
riCI + Cv¯
ri + λb:air
, Ca,i = λb:air
riCI + Cv¯
ri + λb:air
, (4.18)
where ri = vi/qi and Ca,i is the arterial concentration.
We take into account that alveolar capillaries are connected in parallel,
so that the composition of the mixed venous blood and of the inspired air is
the same for different alveoli. Furthermore, the pulmonary blood flow is the
sum of the blood flows of the individual alveoli and the alveolar ventilation
is the sum of the individual alveolar ventilations, so we get
V˙A =
∑
i
viV˙A , Q˙c =
∑
i
qiQ˙c . (4.19)
The mixed alveolar air is a mixture of air samples from different alveoli
and is calculated by the ventilation-weighted average of the gas coming
from each compartment. Similarly, the systemic arterial blood is a mixture
of arterial blood flowing through the pulmonary capillaries of the various
alveoli and thus is the perfusion-weighted mean of the blood coming from
each compartment. The mean alveolar concentration (CA) and the mean
arterial concentration (Ca) are given by
CA =
∑
i
viCA,i Ca =
∑
i
qiCa,i . (4.20)
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Even though in each individual alveolus diffusion equilibrium between
end-capillary blood and alveolar air holds, no such equilibrium is required
between the mean arterial and mean alveolar concentrations. Under steady
state conditions as described in Equation (4.18), it can be shown that mean
arterial and mean alveolar concentrations are in equilibrium only if the
ventilation-perfusion ratio is uniform throughout the lung (see [43]). This
means that if we denote the ventilation-perfusion ratio for the lung as a
whole by r0, ri = r0 holds for all i.
To sum up, assuming that each parallel lung compartment is in steady
state at every time instant and that the ventilation-perfusion ratios ri are
uniform throughout the lung, it can be concluded that mean arterial and
mean alveolar concentrations are in equilibrium according to Henry’s Law
(Ca = λb:airCA) and the mass-balance equation of the homogeneous lung
corresponds to the basic model equation (1.2) described in Section 1.4.
In the following we only make use of the assumption that in each sub-
compartment of the lung a diffusion equilibrium between end-capillary blood
and alveolar air holds (CA,i = λb:airCa,i), and so we construct a three com-
partment lung model. A sketch of this model is given in Figure 4.4.
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Figure 4.4 – Sketch of the 3 compartment lung model. Compartments are
connected in parallel.
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The mass-balance equations for the alveolar compartments read
V˜A,1
d
dt
CA,1(t) = q1Q˙c(t) (Cv¯(t)− CA,1(t)λb:air)− v1V˙A(t)CA,1(t) , (4.21)
V˜A,2
d
dt
CA,2(t) = q2Q˙c(t) (Cv¯(t)− CA,2(t)λb:air)− v2V˙A(t)CA,2(t) , (4.22)
V˜A,3
d
dt
CA,3(t) = q3Q˙c(t) (Cv¯(t)− CA,3(t)λb:air)− v3V˙A(t)CA,3(t) . (4.23)
Multicompartment lung models with severe V˙A/Q˙c heterogeneity have
been suggested by several investigators [45, 89], mostly consisting of a non-
ventilated compartment (V˙A/Q˙c = 0), a non-perfused compartment (V˙A/Q˙c ≈
∞), and a ”perfect” compartment (V˙A/Q˙c ≈ 1). However, we prefer to make
use of the quantitatively more realistic example suggested by Hlastala [42]
of the three compartment representation of the normal lung given in Table
4.2. This lung model has a low V˙A/Q˙c compartment representing the shunt,
a normal compartment, and a high V˙A/Q˙c compartment representing the
dead space.
fractional ventilation (vi) fractional perfusion (qi)
Compartment 1 0.1 0.2
Compartment 2 0.75 0.76
Compartment 3 0.15 0.04
Table 4.2 – Three compartment lung with shunt and dead space as suggested
in [42].
In normal subjects, the more uniform topographical distribution of blood
flow during exercise results in a much more uniform matching of ventilation
and perfusion throughout the lung, and the whole lung ventilation-perfusion
ratio increases to a range of 2 to 4 with an average of 2.5 [62,118]. For this
reason we assume that the fractional flows are uniformly distributed with
the start of exercise and approximate them by piecewise linear functions.
If we replace this three compartment representation of the lung with the
homogenous lung of the five compartment model described in Section 4.1,
we see that the combined model is still lacking to explain the observed
concentrations of isoprene under workload. Since the only source of isoprene
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is situated in the liver compartment and workload causes a decrease of the
fractional blood flow through the liver compartment, an increase in the
exhaled concentration can not be achieved in response to exercise.
With respect to the model assumptions about the sources and sinks of
isoprene, it can be concluded that the three compartment representation
of the lung is capable to explain the peak shaped isoprene profile only if
an extreme distribution of the fractional flows qi and vi are assumed. This
distribution needs to allow a high concentrated accumulation of isoprene in
the lung under steady state conditions. This means that in steady state, the
most perfused lung compartment must get the least ventilation to lead to
an enhanced isoprene excretion when the ventilation-perfusion distribution
becomes much more uniform at the start of the exercise. Compared to a
shunt perfusion of about 3% and a dead space ventilation of about 25% in
normal lung [42], this values are physiologically not realistic and they lead
to an extremely high mixed venous concentration in steady state which is
in contraction to the values of about 9 nmol/l given in the literature [74].
An example of the above description is given in Figure 4.5. Thereby,
the lung is treated as consisting of a pure dead space compartment, an
ideal compartment, and a pure shunt compartment. A lumped well-mixed
homogenous body compartment with a constant production rate and a linear
metabolic elimination is considered.
0 5 10 15 20 25 300
50
100
150
200
250
300
350
400
time [min]
co
nc
en
tra
tio
n 
[p
pb
]
 
 
0
50
100
ve
no
us
 co
nc
. [
nm
ol/
l]
exhaled isoprene
venous concentration
3 compartment lung model
flo
ws
[l/m
in]
time [min]
 
 
0 5 10 15 20 25 300
5
10
15
20
25
30
cardiac output
alveolar ventilation
Figure 4.5 – Simulation result of the exhaled isoprene behavior during er-
gometer exercise at 75 W (the three compartment lung model combined with
a lumped body compartment).
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The mass-balance for the body compartment is governed by the following
differential equation
V˜body
dCbody(t)
dt
= Q˙c(t) (Ca(t)− Cbody(t)λb:body)
+ kpr − kmetCbody(t)λb:body . (4.24)
Parameters for this simplified model are given in Table B.3.
4.4 Stratified Inhomogeneity
Stratified inhomogeneity refers to the regional inhomogeneities in the
lung in terms of a diffusion conductance term as described in Section 1.4.
The theory is developed by Scheid et al. [97]. In this suggested series model,
the lung is assumed to consist of a proximal compartment and a distal com-
partment. The proximal lug compartment is not perfused, but continuously
ventilated, and it exchanges gas by diffusion with the distal compartment.
The distal compartment is not ventilated but perfused with a continuous
blood flow and exchanges gas by diffusion with both the proximal com-
partment and capillary blood. A perfect diffusion equilibration between
the blood in the capillary and the alveolar air contained in the distal lung
compartment is assumed. So the storage capacity of the combined distal
compartment is governed by the effective volume V˜A,2 := VA,2 + Vcλb:air,
where VA,2 and Vc denote the gaseous volume of the distal compartment
and the volume of the blood contained in the capillaries, respectively. Dif-
fusion across the alveolar membrane between both lung compartments is
assumed to be rate-limiting and quantified by the substance-specific diffu-
sion conductance D. A sketch of the model structure is given in Figure
4.6.
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Fig. 7 Equations (??)–(??) viewed as generalized model including several gas exchange mechanisms as
special cases (CI = 0).
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Figure 4.6 – Sketch of the stratified lung model.
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For simulation purposes under exercise conditions, we model the diffusion
conductance D as a function of time being linear dependent on the alveolar
ventilation V˙A as
D(t) = Drest + τ
(
V˙A(t)− V˙ restA
)
, τ > 0 . (4.25)
We have chosen the constant τ to be 0.85, which has the following influence
on the gas exchange mechanism of the lung. During steady state, the small
conductance term Drest reduces the gas exchange efficiency by causing a dif-
fusion limitation between the proximal and distal lung compartments. As
ventilation increases with the start of exercise, due to more efficient mixing
of the gases resident in both lung compartments, the diffusion conductance
increases and the lung becomes more efficient.
The model is described by the following differential equations.
Proximal compartment
VA,1
dCA,1(t)
dt
= −CA,1(t)V˙A(t) +D (CA,2(t)− CA,1(t)) , (4.26)
and distal compartment
V˜A,2
dCA,2(t)
dt
= Q˙c(t) (Cv¯(t)− CA,2(t)λb:air(t))−D (CA,2(t)− CA,1(t)) .
(4.27)
A single body compartment presented as before is introduced and the mass
balance in this compartment is described by
V˜body
dCbody(t)
dt
= Q˙c(t) (CA,2(t)λb:air − Cbodyλb:body)
+ kpr − kmetCbody(t)λb:body . (4.28)
Similar to the arguments for the three compartment lung model, also
for the stratified inhomogeneous lung, the mixed venous concentration has
to be very high for exhaled isoprene to result in a 3 − 4 fold increase over
the steady state levels. An example leading to the initial peak is shown in
Figure 4.7 and the corresponding parameters are listed in Table B.4.
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Figure 4.7 – Simulation result of the exhaled isoprene behavior during ergome-
ter exercise at 75 W (the stratified lung model is combined with a lumped body
compartment).
4.5 Discussion to the Aforecited Models
The lipophilic behavior of isoprene (as expressed by a small blood:air
partition coefficient) advices us to consider the effects regarding the func-
tional changes in the lung. However, a physiologically relevant description of
its exhalation dynamics under exercise conditions could not be achieved by
the discussed lung models which take into account regional inhomogeneities
throughout the lung. With the assumption of a constant production rate
in the liver compartment, where exercise leads to a decreased fractional
blood flow, an initial increase of exhaled isoprene concentration can only
be achieved by allowing a high concentrated accumulation in the lung un-
der steady state conditions. This, in turn, requires very high mixed venous
concentrations, which contradicts earlier findings.
We mentioned that in normal subjects, the more uniform topographical
distribution of pulmonary blood flow during exercise results in a relatively
uniform matching of ventilation and perfusion throughout the lung [62,118].
Since during exercise ventilation increases more than perfusion, the overall
ventilation-perfusion ratio increases from a value of about 1 at rest to a
range of 2 to 4 when the intensity of the exercise is increased from moderate
to severe [62]. Other factors remaining unchanged, this effect would cause a
decrease in the exhaled breath concentrations of low soluble VOCs accord-
ing to Farhi’s equation (1.4). Interestingly, exhaled isoprene profiles during
workload challenges drastically depart from this predicted trend, see Fig-
ure 4.9. In contrast, exhaled breath profiles of butane (also a blood-borne
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endogenous VOC) under dynamical exercise obey the qualitative behavior
anticipated from Farhi’s equation (1.4) [54], even though both compounds
are comparable in terms of their physico-chemical properties. In particu-
lar, both butane and isoprene have similar molecular weights and similar
blood:gas partition coefficients and therefore the diffusing capacity of the
lung for both gases should be similar according to Graham’s law (see A.7).
This discrepancy suggests that some compound-specific (release) mechanism
needs to be taken into account for clarifying the physiological behavior of
isoprene.
Regarding the lung, an alternative isoprene source might comprise the
pulmonary surfactant, which is a complex mixture of lipids and specific
proteins lining the epithelial surface of the lung. Within the alveoli, its
main function is to reduce surface tension at the air-liquid interface and
ensure alveolar stability during respiratory motion [63].
A storage function of the pulmonary surfactant for isoprene and a re-
lease mechanism due to the hyperinflation of the lung [117] is conceivable,
however, there is little evidence to pursue this hypothesis. On the other
hand, experimental evidence suggests a systemic source of isoprene as will
be presented in the next section.
4.6 Revealing Information from Experiments
The experimental data presented in the following are taken from the
study cohort in [52] and [53], where five (age 27-34 years, 4 male, 1 female)
and eight (age 25-30, 5 male, 3 female) normal healthy volunteers have been
investigated, respectively. Figure 4.9 shows representative experimental re-
sults for one single volunteer (27 years, male).
All protocols started with an initial resting phase without workload.
Then for the first two protocols the test subject was challenged to pedal
at constant speed between 70-80 rmin−1 on the ergometer, which was set
up for constant workload resistance according to each protocol. In protocol
3 exercise carried out with two subsequent phases of arm-crank exercise
followed by pedaling. Exercise protocols are given in Figure 4.8.
Breath isoprene concentrations are assessed by means of a real-time setup
designed for synchronized measurements of exhaled breath VOCs (using
PTR–MS) as well as a variety of respiratory and hemodynamic parameters
as described in Section 1.3.
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Figure 4.8 – Protocols of the three workload scenarios corresponding to the
data presented in Figure 4.9.
(First column): Two legged ergometer experiment. Protocol: 5 min resting
- 15 min exercise (75 W) - 3 min resting - 15 min exercise (75 W) - 12 min
resting - 5 min exercise (75 W) - 5 min resting.
(Second column): One legged ergometer experiment. Protocol: 3 min resting
- 10 min left leg (50 W) - 4 min resting - 2 min left leg (50 W) - 4 min resting
- 7 min right leg (50 W).
(Third column): Arm/two-legged ergometer experiment. Protocol: 2 min rest-
ing - 5 min arm-crank training (2.5 kg/arm) - 4 min resting - 2 min arm-crank
training (2.5 kg/arm) - 4 min resting - 3 min two-legged exercise (60 W).
The first column of Figure 4.9 presents measurement results during a
2-legged ergometer exercise with three subsequent workload phases at 75
W, and pauses of 3 min and 12 min, respectively. The breath isoprene
concentration profiles during these three workload phases display similar
shape. Nevertheless, the height of the characteristic exercise peak is signifi-
cantly higher during the first phase of workload, despite an almost identical
behavior of cardiac output and alveolar ventilation throughout all exercise
segments. This indicates the existence of a buffer tissue compartment for
isoprene. The concentration peak observed during the first workload phase
is restored if the pauses between workload phases are extended: Approxi-
mately one hour of rest is necessary to achieve a complete recovery of the
initial peak height [53].
The second column of Figure 4.9 shows representative results in response
to one-legged ergometer exercise at 50 W. After 10 minutes of pedaling with
the left leg, breath isoprene profiles closely resemble the two-legged case and
a clear washout effect emerges, yielding a lower peak height when continuing
the exercise with the same leg. However, if the working limb is switched to
the right leg after a short break of the same length as before, an immediate
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recovery of the initial peak size can be observed. The observation that
the rise in cardiac output and alveolar ventilation is of comparable order
in all three phases of exercise appears to exclude functional changes of the
lung (redistribution of ventilation-perfusion ratio, distension of pulmonary
capillaries) as the main cause for the peak-shaped isoprene profile at the
onset of exercise and strongly supports the hypothesis of a peripheral source
affecting breath isoprene output.
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Figure 4.9 – Typical smoothed profiles of end-exhaled isoprene concentrations
and physiological parameters in response to predefined workload scenarios of
one single volunteer (27 years, male).
The experiment presented in the third column of Figure 4.9 allows for
a more precise specification of the location of the above-mentioned tenta-
tive isoprene buffer, namely skeletal muscles, by stimulating single muscle
groups with distinct masses. While repeated dynamic arm-crank exercises
with an intermediate pause of 4 minutes yield the same washout effect as
described above, subsequent two-legged ergometer exercise at 60 W yields a
much higher peak compared to arm-crank exercise, despite a similar behav-
ior of the ventilation-perfusion ratio within all three workload segments. We
attribute this effect to the smaller mass of arm musculature as well as to the
smaller fractional perfusion of the arm muscle group as compared to leg mus-
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culature. This experiment proposes that a major part of isoprene variability
during exercise conditions can be ascribed to an increased fractional perfu-
sion of the working locomotor muscles, eventually leading to higher isoprene
concentrations in mixed venous blood at the onset of physical activity.
This rationale is in accordance with the predominant physiological role of
working muscle during exercise. Collectively, the skeletal muscles constitute
up to 40-45% of body weight, which is more than any other single organ.
At rest, about 10–15% of cardiac output is distributed to skeletal muscle,
while during strenuous exercise skeletal muscle may receive more than 80%
of total blood flow, thus rendering it as one of the major factors in overall
cardiovascular hemodynamics [76].
4.6.1 A first three compartment model for isoprene
In the light of the experiments outlined above the mathematical model of
isoprene distribution presented here is based on the assumption of a periph-
eral source of isoprene in the body. The lung is considered to be a homoge-
nous single compartment with a fixed storage volume VA. An instantaneous
equilibrium between end-capillary blood (corresponding to arterial blood)
and alveolar air is assumed, leading to a directly proportional relationship
(Henry’s law (A.9)) between the arterial blood concentration Ca and the
alveolar air concentration CA, viz.,
Ca = λb:airCA. (4.29)
Here, λb:air is the dimensionless substance specific partition coefficient be-
tween blood and air. In view of this diffusion equilibrium, the alveolar
compartment capacity is governed by the effective storage volume V˜A :=
VA + λb:air Vc′ , where Vc′ represents the capillary blood volume. Thus, the
mass-balance equation for the lung reads according to (2.7)
V˜A
dCA
dt
= Q˙c (Cv¯ − Ca) + V˙A (CI − CA) , (4.30)
where Cv¯ and CI are the concentrations in mixed venous blood and inhaled
air, respectively. Cardiac output is denoted by Q˙c, while V˙A denotes the
alveolar ventilation.
The body is subdivided into two homogenous functional units: a richly
perfused tissue compartment (including intestines, liver, brain, connective
muscles and skin) and a peripheral tissue compartment. The model structure
is sketched in Figure 4.10. While production and metabolic elimination of
isoprene occurs in both compartments, the peripheral tissue compartment
takes the role of an isoprene buffer and is postulated to contain the working
muscle compartment, which receives a disproportionally high fraction of the
systemic blood flow as soon as exercise starts.
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The venous blood concentration leaving the compartment is considered
to be in equilibrium with the respective tissue concentration at every instant
t (venous equilibrium). Based on this assumption, the storage capacities in
richly perfused and peripheral tissue can again be expressed as effective vol-
umes V˜rpt := Vrpt + λb:rpt Vrpt,b and V˜per := Vper + λb:per Vper,b, respectively.
Here, V? and V?,b denote the volumes of intracellular space and vascular
blood, respectively, while λb:? is the blood:tissue partition coefficient of the
corresponding compartment 1. Mass balance equations read
V˜rpt
dCrpt
dt
= (1− qper)Q˙c(Ca − λb:rptCrpt) + krptpr − krptmetλb:rptCrpt , (4.31)
for richly perfused tissue and
V˜per
dCper
dt
= qperQ˙c(Ca − λb:perCper) + kperpr − kpermetλb:perCper , (4.32)
for peripheral tissue, with the kinetic rate constants k?pr and k
?
met describ-
ing production and metabolic elimination, respectively, and q? denoting a
fractional blood flow. 1
CI
!
CA
"V˙A
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Q˙
c
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Vc′
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Crpt,b
Vrpt,b
Crpt
Vrpt
(1−qper)Q˙c
qperQ˙c
ﬀ
krptmet$
krptprﬀ
peripheral tissue
compartment
Cper,b
Vper,b
Cper
Vper
kpermet$
kperprﬀ
ﬀﬀ
ﬀ
"
$
Figure 4.10 – Sketch of the model structure. The body is divided into three
distinct functional units: alveolar/end-capillary compartment (gas exchange),
richly perfused tissue (metabolism and production) and peripheral tissue (stor-
age, metabolism and production). Dashed boundaries indicate a diffusion equi-
librium. Abbreviations connote as in Table 4.3.
CHAPTER 4. MODELING ISOPRENE 71
In order to capture the redistribution of the systemic perfusion during
ergometer exercise, the fractional blood flow qper ∈ (0, 1) to peripheral tis-
sue is assumed to resemble the fractional blood flow to both legs, which is
approximated to increase with cardiac output according to
qper(Q˙c) := qrestper +(q
max
per −qrestper )×
(
1−exp (−τ max{0, Q˙c − Q˙
rest
c
Q˙restc
})), (4.33)
where τ > 0 is a constant. The associated concentrations in mixed venous
and arterial blood are given by
Cv¯ := (1− qper)λb:rptCrpt + qperλb:perCper (4.34)
and Equation (4.29), respectively. Moreover, we state that the measured
(end-tidal) isoprene concentration equals the alveolar level, i.e.,
Cmeas = CA. (4.35)
Discussion to this model
During rest, the peripheral compartment is characterized by high iso-
prene concentrations resulting from extrahepatic production with a con-
stant rate. However, due to the minute fractional blood flow to these tis-
sues, mixed venous concentrations are mainly governed by the lower isoprene
content in venous blood returning from the richly perfused tissue group. At
the start of exercise, the fractional perfusion in the periphery increases and
the mixed venous concentrations become dominated by peripheral venous
return. The isoprene concentration peak visible in breath hence is consid-
ered as a consequence of the corresponding increase in the underlying mixed
venous concentration.
While the cause and effect relationships proposed above remain specu-
lative, the presented modeling study (see also [52] and [56]) certainly yields
new interesting perspectives on previous experimental findings. Several ex-
periments have been summarized here demonstrating that the peak-shaped
behavior of end-tidal isoprene during exercise is most probably associated
with the increased activity and perfusion of the skeletal muscle group.
The simulation result given in Figure 4.11 shows a perfect match between
observed data and model output by means of the three compartment model.
For a detailed description of model validation and estimation we refer to [52].
To make a more precise description of the peripheral origin of isoprene
in the following we will formulate a five compartment model similar to that
given by Filser et al. [30] with some adaptations based on the experimental
findings described above. Attention will be paid to the original compartmen-
tal segmentation. A further requirement is the description of the exhaled
isoprene profiles of the one-legged exercise (as presented in Figure 4.9) by
means of the extended model.
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Figure 4.11 – Simulation result of the three compartment peripherie model
taken from [52].
4.7 A Five Compartment Model
The following five compartment model maintains the compartmental seg-
mentation of the toxicokinetic physiological five compartment model intro-
duced by Filser [30]. Only the muscle compartment will be understood now
as working muscle compartment containing skeletal muscles, whereas resting
muscles and skin are included in the RPT compartment. In the muscle com-
partment, we assume a metabolic activity concerning isoprene expressed by
a constant production rate and by a linear kinetic for metabolic elimination.
A sketch of the model structure is given in Figure 4.12. The mass balance
equations are derived in the same way as before and listed below.
The mass balance equations for the alveolar compartment reads
V˜A
dCA(t)
dt
= V˙A(t) (CI − CA(t)) + Q˙c(t) (Cv¯(t)− Ca(t)) , (4.36)
while for the RPT, liver and working muscle compartments we find that
V˜rpt
dCrpt(t)
dt
= qrpt(t)Q˙c(t) (Ca(t)− λb:rptCrpt(t))
− krptmetλb:rptCrpt(t) , (4.37)
V˜liv
dCliv(t)
dt
= qliv(t)Q˙c(t) (Ca(t)− λb:livCliv(t))
+ klivpr − klivmetλb:livCliv(t) , (4.38)
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and
V˜mus
dCmus(t)
dt
= qmus(t)Q˙c(t) (Ca(t)− λb:musCmus(t))
+ kmuspr − kmusmetλb:musCmus(t) (4.39)
respectively. Finally, for the fat compartment we have
V˜fat
dCfat(t)
dt
= qfat(t)Q˙c(t) (Ca(t)− λb:fatCfat(t)) . (4.40)
The mixed venous concentration is given as the weighted average of the
compartmental venous concentrations
Cv¯(t) := qrpt(t)λb:rptCrpt(t) + qfat(t)λb:fatCfat(t) (4.41)
+ qmus(t)λb:musCmus(t) + qliv(t)λb:livCliv(t) .
The alveolar concentration is assumed to be proportional to the arterial
concentration
Ca(t) = λb:airCA(t) , (4.42)
and again, we state that the measured (end-tidal) isoprene concentration
equals the alveolar level, i.e.,
y := Cmeas = CA . (4.43)
The redistribution of the systemic perfusion during ergometer exercise is
described by the following equations.
qrpt(Q˙c) := qrestrpt − (qrestrpt − qminrpt )×
(
1− exp (−τrpt max{0, Q˙c − Q˙
rest
c
Q˙restc
})),
qfat(Q˙c) := constant ,
qmus(Q˙c) := qrestmus + (q
max
mus − qrestmus)×
(
1− exp (−τmus max{0, Q˙c − Q˙
rest
c
Q˙restc
})),
qliv(Q˙c) := 1−
(
qrpt(Q˙c) + qfat(Q˙c) + qmus(Q˙c)
)
.
Here, qi ∈ (0, 1) designates the fractional blood flow to the compartment i
and τrpt, τmus are positive constants.
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Fig. 1 Sketch of the model structure. The body is divided into five distinct functional units: alveolar/end-
capillary compartment (gas exchange), richly perfused tissue (metabolism and production, includes rest-
ing muscle, skin, intestines, brain, kidney, spleen and other organs), fat compartment (storage), working
muscle compartment (metabolism and production), and liver compartment (metabolism and production).
Dashed boundaries indicate a diffusion equilibrium.
ure 4.12 – Sketch of h model structure. The body is divided nto five
distinct functional units: alveolar/end-capillary compartment (gas excha ge),
richly perfused tissue (metabolic elimination) includes resting muscle, skin, in-
testines, brain, kidney, spleen and other organs), fat compartment (storage),
working muscle compartment (metabolic elimination and production), and
liver compartment (metabolic elimination and production). Dashed bound-
aries indicate a diffusion equilibrium.
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As before, the compartment capacities are defined as
V˜A := VA + Vc′λb:air ,
V˜rpt := Vrpt + Vrpt,bλb:rpt ,
V˜fat := Vfat + Vfat,bλb:fat ,
V˜mus := Vmus + Vmus,bλb:mus ,
V˜liv := Vliv + Vliv,bλb:liv .
For later purposes, we note that a model accommodating the experi-
mental situation during exhalation and inhalation to and from a fixed vol-
ume exposure atmosphere can simply be derived by augmenting Equations
(4.36)-(4.38) with an additional compartment obeying
V˜I
dCI(t)
dt
= V˙A(t) (CA(t)− CI(t)) . (4.44)
This typically describes closed system (rebreathing) setups such as in Filser
et al. [30]. The external measurable inputs are denoted by
u := (V˙A, Q˙c, CI) and p := (kmuspr , k
liv
pr , k
rpt
met, k
mus
met , k
liv
met, V˜mus, τmus) represents
the constant vector of parameters to be estimated from measured breath
concentrations y.
In the following, we will discuss some qualitative properties of the un-
derlying system. Note first that Equations (4.36)-(4.38) can be written as a
time-varying inhomogenous linear system
c˙ = A(u,p)c+ b(u,p) =: f(u,p, c) . (4.45)
As the system is linear, for any given initial condition c(0) there is a unique
global solution. According to the Remark 3.1.4 in Section 3.1 we know that
the positive orthant Rn+ is a forward invariant set for our system. That
means, the components of the state variable c = (CA, Crpt, Cfat, Cmus, Cliv)
T
remain non-negative for all t. Moreover, by considering the total mass of
substance contained in the system we postulate that the trajectories of the
system remain bounded for bounded rates of production and metabolic elim-
ination. Indeed, if we define m as a continuously differentiable function
m :=
∑
i
V˜iCi ≥ 0 , (4.46)
we obtain
m˙ = V˙A(CI − CA)− krptmetCrptλb:rpt (4.47)
+ kmuspr − kmusmetCmusλb:mus + klivpr − klivmetClivλb:liv .
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By considering the positivity of all involved parameters, it can readily be ver-
ified that the trajectories remain bounded. Moreover, for constant u (which
corresponds to rest or constant workload conditions) the compartmental con-
centrations have been shown to approach a globally asymptotically stable
equilibrium (compare (3.26)), since for this case we achieve that
m˙ = −CAV˙A−krptmetCrptλb:rpt−kmusmetCmusλb:mus−klivmetClivλb:liv ≤ 0 . (4.48)
Thus, m is a Lyapunov function of the homogenous system and the trajecto-
ries approach the asymptotically stable equilibrium point ce(u) := −A−1b
according to the argumentation in Remark 3.1.4.
Based on the isoprene profiles observed during moderate ergometer chal-
lenges of one representative single test subject our aim is now to (at least
partially) determine the subject-dependent parameter vector
p = (kmuspr , k
liv
pr , k
rpt
met, k
mus
met , k
liv
met, V˜mus, τmus)
as well as the nominal endogenous steady state levels c0 = c(t0) by solving
the OLS problem
argminc0,p
n∑
i=0
(yi − CA(ti))2 . (4.49)
Here yi = Cmeas,i is the measured end-tidal isoprene concentration at time
instant ti (t0 = 0). The optimization problem is subject to the constraints
g(u0,p, c0) = 0 (steady state)
p, c0 ≥ 0 (positivity)
ce6(u0,p) = 25 nmol/l (exposure steady state).
(4.50)
The vector function g is the right-hand side of the ODE system (4.36)-(4.38)
and the last constraint complies the inhalation studies provided by Filser
et al. [30]. This has been introduced to account for additional information
regarding the biotransformation of isoprene. The solution point will be
denoted by (pˆ, cˆ0).
Under normal conditions (apart from inhalation studies) the atmosphere
is assumed to be free of isoprene since ambient air isoprene concentrations
are generally less than 10 ppb [81] and thus are considered as negligible.
For simulations purposes the measured physiological functions V˙A and Q˙c
were converted to input function handles u by applying a local smoothing
procedure to the associated data and interpolating the resulting profiles with
sum of sine functions. Tissue volumes and partition coefficients are as in
Table B.1. Parameters corresponding to the fractional blood flows are given
below.
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Parameter Symbol Nominal value (units)
Fractional blood flows
Fat qfat 0.03
RPT qrestrpt , q
min
rpt 0.55, 0.22
Muscle qrestmus, q
max
mus 0.1, 0.7
Constant τmus 1.22
Table 4.3 – Reference values for model parameters. Compare also Table B.1.
The above minimization problem has been solved by using the Matlab
routine fmincon (see Section 3.2.4). Fitted parameter values and initial
conditions are given in Table 4.4 and Figure 4.14 shows the simulation result.
Local identifiability of the estimated parameters in Table 4.4 was inves-
tigated by checking the non-singularity of the information matrix Q := STS
according to the sensitivity identifiability as described in Section 3.2.5.
Thereby, the sensitivity the ith row of the sensitivity function matrix S
is given by
Si,− :=
(
∂y(ti−1, pˆ, cˆ0)
∂p
∂y(ti−1, pˆ, cˆ0)
∂c0
)
. (4.51)
Normalized sensitivities are obtained by multiplying each term of the
sensitivity function matrix S by the ratio of the parameter over the ob-
servation y as discussed in Section 3.2.5. To take into account the noise
in the measurements and the numerical accuracy, we adopted the standard
numerical rank criterion
rankQ = max{k; σk > ε ‖Q‖∞} , (4.52)
where σ1 ≥ σ2 ≥ · · · ≥ 0 are the singular values of Q and ε = 10−8 denotes
the maximum relative error of the calculated sensitivities [36]. We find
that the information matrix Q has full rank suggesting that all estimated
parameters are practically identifiable.
However, some degree of ill-conditioning is present as can be concluded
from calculating the approximate posterior correlation matrix R defined by
Ri,j := Q−1i,j
(
Q−1i,i Q
−1
j,j
)1/2 ∈ [−1, 1] . (4.53)
The entry Ri,j quantifies the degree of interplay between the ith and jth
elements of the parameter vector (pˆ, cˆ0). A value of Ri,j near +1 or −1
indicates that it may be difficult to estimate both parameters separately, as
changes in the model output caused by perturbing one of these parameters
can nearly be compensated by an appropriate perturbation of the other
[46,92].
High correlations are achieved between the elements of the parameter
vector (kmusmet , k
mus
pr , Cmus(0), V˜mus) and for the pair (k
rpt
met, Crpt(0)) in a range
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of absolute values between 0.9541 and 0.9944. This indicates a poor estima-
bility of the above-mentioned parameter pairs if only the breath isoprene
dynamics in Figure 4.14 are taken into account. However, the constraints
in (4.50) provide additional information on these parameters that will prove
sufficient for guaranteeing the extraction of reliable estimates.
Parameter Symbol Nominal value (units) CV
Metabolism rate RPT krptmet 1.22 (l/min) 2.86
Production muscle kmuspr 97.31 (nmol/min) 0.31
Metabolism rate muscle kmusmet 0.9 (l/min) 0.66
Production liver klivpr 8.5 (nmol/min) 3.14
Metabolism rate liver klivmet 2.06 (l/min) 3.92
Initial concentration alveoli CA(0) 5.5 (nmol/l) 0.03
Initial concentration rpt Crpt(0) 7.08 (nmol/l) 0.86
Initial concentration fat Cfat(0) 412.5 (nmol/l) 17.42
Initial concentration muscle Cmus(0) 136.46 (nmol/l) 0.11
Initial concentration liver Cfat(0) 10.57 (nmol/l) 0.11
Volume muscle V˜mus 11.34 (l) 0.09
Constant muscle comp. τmus 1.95 0.04
Table 4.4 – Decisive model parameters resulting from the fit in Fig. 4.14. The
corresponding coefficients of variation (CV, in %) were obtained by the use of
traditional sensitivities according to the stardard error approach.
To determine the parameter and initial concentrations to which the
model solution is most sensitive, we use the information obtained from the
semi-relative sensitivities over the observation interval [t0, tn] and calculate
the L2−norm in time to get an overall measure thereof, viz.,
ζ(pj) :=
∫ tn
t0
(
∂y(t, pˆ, cˆ0)
∂pj
∂pˆj
maxs|y(s)|
)2
dt , (4.54)
and similarly for the components of c0. From the graphical comparison of
these sensitivity indices we can conclude that the output is mostly influenced
by kmuspr , Cmus(0), V˜mus, and τmus.
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Figure 4.13 – Squared L2-norm of the semi-relative sensitivities
(cf. Eq. (4.54)) with respect to the fitted parameters in Table 4.4.
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Figure 4.14 – Two-legged ergometer exercise at 75 W with intermediate
pauses of varying lengths. First row shows observed (in red) versus simulated
(in black) isoprene profiles.
Protocol: 5 min resting - 15 min exercise (75 W) - 12 min resting - 15 min
exercise (75 W) - 3 min resting - 5 min exercise (75 W) - 5 min resting.
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The interpretation of the model output with respect to exercise is the
same as in three compartment model, but the presented five compartment
model has verified the assumption of a muscle compartment to be the main
source of exhaled isoprene. The leg contraction experiment presented in
Figure 4.7 also confirms that a release mechanism resulting from an increased
venous return from the contracting muscles plays an important role in the
obverved peak in breath isoprene concentration.
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Figure 4.15 – Leg contraction at minutes 1, 6, and 11.
The estimated parameters in both models are of comparable order. More-
over, arterial and mixed venous concentrations at the start of the experiment
are in line with data available from the literature.
The estimated arterial concentration Ca(0) = 4.12 nmol/l and mixed venous
concentration Cv¯(0) = 10 nmol/l are in direct accordance with available
data from the literature [74]. Total endogenous production is approximately
111.96 nmol/min, which is comparable to previous predictions ranging from
2.5 to 5.7 nmol/min/kg bodyweight [30,38]. Moreover, the estimated value
for V˜mus lies in the range (7.5 - 12 l) of experimentally measured thigh muscle
volumes in [108].
Recall the effect of the one-legged exercise from Figure 4.9 where switch-
ing the working limb caused an immediate recovery of the initial peak size.
Figure 4.16 shows simulation results of the one-legged exercise by the means
of a six compartment model, adapted by dividing the muscle compartment
into two parts representing each leg. Blood flows through the limbs are
defined such that the resting limb gets half of the steady state blood flow
CHAPTER 4. MODELING ISOPRENE 81
whereas the working limb gets the rest. The parameter values are listed in
Table 4.5.
The one-legged exercise was performed by the same test subject at a
different time with a steady state breath concentration of CA = 5.34 nmol/l.
Consequently, other compartmental initial concentrations were also changed
as they can be calculated from the model equations (4.36)-(4.38) for steady
state conditions. If the metabolic parameters krptmet, k
liv
pr , and k
liv
met are kept
constant, the observed isoprene profile is approximated by the simulated
profile, only by modified parameters of the working muscle compartment.
(The parameter values are listed in Table 4.5).
First, the increase in fractional blood flow from rest to work is faster
compared to the two-legged exercise. A greater relative perfusion of the
single leg has been suggested by Davies and Sargeant [23] to explain why
one-leg peak oxygen uptake is greater than 50 % of the two-leg value during
unilateral compared to bilateral cycling. Additionally, a physiological phe-
nomenon known as bilateral deficit (BD) may be responsible for this effect.
Bilateral deficit states that during a movement that requires simultaneous
activation of both limbs total force exerted by two limbs is less than the
sum of the force produced by the left and right limbs acting alone. Thus,
an increased activation of the musculature is conceivable when switching to
one-legged cycling.
In general, the evidence of BD is suggested only during isokinetic bilat-
eral activations of homogenous muscle groups. In isokinetic contractions,
the muscle contracts and shortens at constant speed. A specialized appa-
ratus that provides variable resistance is needed to keep the speed constant
irrespective of how much effort is exerted. In our laboratory exercise tests
are carried out on a medical ergometer operating at constant levels of power,
independent of pedal speed. Thus the influence of the aforementioned mech-
anism of BD is questionable in this case. However, it has been shown by
Dunstheimer et al. [25] by unilateral versus bilateral cycling experiments
that BD also exists for more complex, alternating movements, e.g., short-
term and high intensity cycling. Although the underlying exact mechanisms
are not understood in sufficient deep, yet, compared to with unilateral cy-
cling, a decreased activation of the muscles involved during bilateral cycling
of the legs may explain the observed BD [25]. More specifically, it has been
suggested that during cycling, the BD might be attributed to a larger total
muscle mass involved in the unilateral cycling tasks compared to the bilat-
eral test. If the foot of the working leg is fixed during unilateral cycling,
the involved leg has to actively pull up and push down. In contrast, during
the bilateral cycling the test subject has only to push down on the pedal,
thereby not using the entire leg musculature. This argumentation is in ac-
cordance with the estimated enhanced production rate kmuspr and the muscle
volume V˜mus.
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Parameter Symbol Nominal value (units)
Initial concentration alveoli CA(0) 5.34 (nmol/l)
Initial concentration rpt Crpt(0) 7.13 (nmol/l)
Initial concentration fat Cfat(0) 401 (nmol/l)
Initial concentration muscle (each leg) Cmus(0) 148.44 (nmol/l)
Initial concentration liver Cfat(0) 10.43 (nmol/l)
Constant τrpt 2.7
Constant τmus 3.6
Production muscle kmuspr 195 (nmol/min)
Metabolism rate muscle kmusmet 1.98 (l/min)
Volume muscle V˜mus 13.6 (l)
Table 4.5 – Decisive model parameters resulting from the fit in Fig. 4.16.
iso
pr
en
e
[p
pb
]
0 5 10 15 20 25 300
100
200
300
400
ca
rd
iac
 o
ut
pu
t
[l/m
in]
0 5 10 15 20 25 300
5
10
15
alv
. v
en
tila
tio
n
[l/m
in]
0 5 10 15 20 25 300
10
20
30
40
??
??
???
???
??
??
??
??
??
?
ra
tio
 [ 
]
time [min]
0 5 10 15 20 25 300
1
2
3
Figure 4.16 – Ergometer exercise at 50 W with intermediate pauses of varying
lengths.
Protocol: 3 min resting - 10 min exercise left leg (50 W) - 4 min resting - 2 min
exercise left leg (50 W) - 4 min resting - 7 min exercise right leg (50 W)
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4.8 Discussion and Conclusions
The interplay between mathematical modeling and theory-driven exper-
imentation has finally led us to a mathematical description of isoprene ki-
netics which respects all current data and which furthermore allows for new
predictions that can be tested by adequate experiments.
The origin of endogenous isoprene in humans is mainly attributed to the
mevalonate pathway of cholesterol biosynthesis [24, 50, 105]. The synthesis
of mevalonate is inhibited by statins, which are used in the treatment and
prevention of cardiovascular diseases by lowering serum cholesterol levels.
The primary mechanism of action exerted by statin therapy is to competi-
tively inhibit the activity of HMG-CoA reductase, which is the rate limiting
enzyme in cholesterol synthesis [29]. Correspondingly, it has been reported
that the administration of specific statins (such as lovastatin and atorvas-
tatin) causes a proportional decline in breath isoprene concentrations and
serum cholesterol levels [50, 105]. On the other hand, several studies have
pointed out myotoxic effects to be a major adverse reaction of statin therapy,
leading to the inhibition of skeletal muscle activity [27,29,116].
The extent to which the mevalonate pathway accounts for isoprene for-
mation under physiological conditions is still a matter of debate [73,107]. In
particular, the above-mentioned pathway rests on the acid-catalyzed solvol-
ysis of dimethylallyl-diphosphate in the liver which may be insignificant at
physiological pH [100, 101]. In many plants, the formation of isoprene is
enzyme-catalyzed, and isoprene seems to play a role in the heat protection
of leafs [102]. Moreover, some indications of an isoprene synthase in bovine
liver have been put forward in [100]. Hence, it cannot be excluded that an
isoprene synthase is present in human tissues. However that may be, we
suggest an additional peripheral origin of isoprene through the same basic
biochemical pathway. Specifically, by adopting the assumption of a muscu-
lar source of isoprene, statin-induced lowering of isoprene concentration in
the muscles may turn out as the main cause for the reduction of endogenous
isoprene formation and the subsequent decrease of breath isoprene concen-
trations. An analogous argument might also give further insights into the
surprising lack of statistically significant correlations between breath iso-
prene levels and blood cholesterol levels [59,100].
Similarly, the proposed mechanisms may explain the age dependency of
breath isoprene levels by correlating the latter to changes in the individual
muscle mass. The characteristic median breath isoprene concentration in
adults under resting conditions is about 100 ppb [59], whereas young chil-
dren have demonstrably lower isoprene levels [65,103,107]. Breath isoprene
concentrations have been reported to be non-detectable in the breath of
neonates, while steadily increasing in teenagers and reaching a plateau level
in the middle age [90,103]. Moreover, isoprene levels in older people appear
to decrease [59,90].
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Former investigations with respect to the age dependency of isoprene
output and its reduction under statin therapy nicely fit into this rationale.
Moreover, the present work suggests that the major part of physiologically
formed isoprene stems from the skeletal musculature rather than hepatic
production.
Appendix A
Physical Preliminaries
A.1 The Ideal Gas Law
The intuitive concepts concerning the behavior of gases with relation to
changing conditions are the basis for the ideal gas law. A gas consists of free
molecules in a state of random motion and its molecules fill any container
in which they are enclosed. The ideal gas law expresses the relationship
between pressure (P ), volume (V ), absolute temperature (T ), the number
of moles of gas (n) and the gas constant (R)
PV = nRT . (A.1)
In respiratory physiology, P is usually measured in millimeters of mercury
(mmHg), V in liters (l), and T in Kelvin (K). One mole is per definition the
amount of substance which consists of 6.023 ·1023 gas particles.The constant
R = 62.36 l · mmHg · mole−1 · K−1 is called the general gas constant 1.
Three empirical gas laws can be derived from the ideal gas law. It
says that for a constant absolute temperature and number of gas molecules,
the pressure and volume are reciprocally related one to the other (Boyle-
Mariottes Law). Also, at a constant pressure and number of gas molecules,
the volume occupied by a gas is directly proportional to the absolute temper-
ature (Gay-Lussacs law). Finally, under constant external conditions with
regard to pressure and temperature, equal volumina of different ideal gases
contain equal amounts of molecules (Avogadros law).
Gases obeying the ideal gas law are called ideal gases, which include
beside oxygen and carbon dioxide all VOCs. The concept of an ideal gas
is a model which only applies when the total pressure is low. This means
specifically that the individual gas molecules can be treated as isolated points
in space, having negligible molecular volume and exerting no intermolecular
forces other than those resulting from perfectly elastic collisions between
1Alternatively one can write PV = NkT , where N is the number of particles and k is
Boltzmann’s constant.
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molecules. This is a reasonable assumption at the low pressures normally
encountered in respiratory physiology because, under these conditions, the
average intermolecular distance is about ten times the average molecular
size. The ideal gas law, therefore, reasonably describes the behavior of
respiratory gases [42].
If the equation (A.1) holds for any ideal gas, then it is also valid for
mixtures of ideal gases. The partial pressure of a single gas specie i in a gas
mixture is defined by
Pi =
niRT
V
. (A.2)
Specifically, for a mixture of N different gas species we may write
PV = (n1 + ...+ nN )RT . (A.3)
Relations (A.2) and (A.3) imply Dalton’s Law
P = P1 + P2 + ....+ PN , (A.4)
which expresses the fact that the total pressure P of a gas mixture equals
to the sum of the partial pressures of its individual components.
Furthermore, it is useful to relate the partial pressure of a gas to its
concentration (i.e., the number of molecules per unit volume). The required
formula is easily obtained by substituting Ci,gas = ni/V into (A.2)
Pi = Ci,gasRT , (A.5)
where Ci,gas is the concentration of the species i in the gas phase.
A.2 Diffusion and Solubility of Gases
The concept of partial pressures can be extended to gases in solution
which is an important item for understanding of blood-gas transport mech-
anisms. Consider the situation where a liquid and a gas are in contact across
the surface of the liquid. Molecules of the gas can enter the liquid and wan-
der for a time among its molecules. They are then said to be dissolved in
the liquid, forming a solution. Molecules in solution can also leave the liq-
uid at its surface and become part of the gas again. A prototypic example
for this situation in the present context is the alveolar-capillary membrane
separating the respiratory microvasculature from the alveoli.
The diffusive flux J of gases through a barrier separating two regions
characterized by distinct partial pressures Pj , j = 1, 2 is governed by Fick’s
first law of diffusion
J =
βDA
`
(P1 − P2) . (A.6)
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While moving between the alveolar space and capillary blood, each gas is
subject to the same anatomically related limitations (cross sectional area
A and thickness of the membrane `). Each gas, however, has a different
solubility β and diffusivity D in the membrane barrier.
Generally, all anatomically and gas related parameters in Equation (A.6)
are lumped together under the term diffusing capacity of the lung (DL) 2.
At the alveolar-capillary interface Equation (A.6) hence simplifies to
J = DL(PA − Pb) , (A.8)
where PA and Pb are the partial pressures in alveolar air and capillary blood,
respectively.
After a sufficient long time under constant conditions, the rate at which
gas molecules enter the solution will become equal to the rate at which they
leave. When this is the case for all of the gases present, the system is said
to be at equilibrium, i.e., J = 0. If the gas molecules move independently
of each other and do not form chemical combinations with some component
of the solvent, the concentration of the gas in solution is proportional to its
partial pressure in the gas. Solutions that obey this law are called simple
solutions. For such solutions, we have
Ci,liquid = αiPi , (Henry’s Law) (A.9)
where Ci,liquid is the concentration of the species i in the solution and αi is
the solubility coefficient (also partition coefficient or Henry’s Law constant)
of that species 3.
At diffusion equilibrium, using (A.5) and (A.9) the partition coefficient
can be expressed as the dimensionless ratio between the concentration of
the species in the solution and its concentration in the gas phase:
λliquid:gas =
Ci,liquid
Ci,gas
= αiRT . (A.10)
The partition coefficient is a measure of the solubility of a gas in a solvent
at equilibrium. In our example λb:air describes the solubility of the gas specie
in blood.
2Graham’s law states that the diffusivity of a gas is inversely proportional to the square
root of its molecular weight MW. Therefore, from (A.6) the relative diffusing capacities
of the lung for two distinct gases can be estimated via
DLgas,1
DLgas,2
=
βgas,1
βgas,2
×
p
MWgas,2p
MWgas,1
. (A.7)
3The solubility coefficient is dependent on both solute and solvent, and is inversely
related to temperature.
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A.3 Unit Conversion Factors for Concentrations
For the following conversion factors, consider that temperature (T) is
given in Kelvin (K). Partial pressure is given either in atmospheric pressure
(atm) with gas constant R = 0.08205 l · atm · mol−1· K −1, or in millimeter
of mercury (mmHg) with gas constant R = 62.32 l · mmHg · mol−1· K −1.
Conversion between Mole Basis (ppb) and Molar Concentra-
tion
Molar concentration is the concentration of a substance expressed in
terms of molarity (denoted by M or mol/l). Using the ideal gas law (A.1),
the amount of moles of an ideal gas in one liter mixture can be expressed by
n
V
=
P
RT
(mol/l) . (A.11)
The concentration of 1 ppb (parts per billion; 1 mole part per one billion
total moles) equals 1 · 10−9 in decimal form. Thus the amount of moles of
1 ppb ideal gas in one liter mixture is
P
RT
1 · 10−9 (mol/l) . (A.12)
Thus, the general formula for the conversion factor from mole basis to molar
concentration is
Cmol/l = Cppb · 10−9
P
RT
. (A.13)
Conversion between Molar Concentration and Mass Concen-
tration
Mass concentration is the mass of a constituent substance divided by the
volume of the mixture, a frequently used unit for mass concentration is grams
per liter (g/l). In order to convert between molar concentration and mass
concentration we need to know the molecular weight (MW ) of the substance
given in g/mol. The conversion formula between molar concentration and
mass concentration is given by
Cg/l = Cmol/l ·MWg/mol . (A.14)
Appendix B
Parameter Values
B.1 Physiological Parameters
Parameter Symbol Value
Compartment Volumea [l]
Arterial blood Va 2.85
Alveolar volume VA 4.1
Richly perfused tissue (RPT) Vrpt 0.83
Fat tissue Vfat 12.78
Resting muscle and skin Vrmus 18.21
Working muscle Vmus 18.21
Liver Vliv 1.51
Compartmental blood volumeb (% of tissue volume)
Richly perfused tissue (RPT) Vrpt,b 10.8
Fat tissue Vfat,b 3.80
Resting muscle and skin Vrmus,b 7.98
Working muscle Vmus,b 2.61
Liver Vliv,b 37.2
Partition coefficientc
blood:air λb:air 0.75
blood:rpt λb:rpt 0.41
blood:fat λb:fat 0.01
blood:muscle λb:mus 0.51
blood:liver λb:liv 0.39
Effective compartment volume [l]
Alveolar V˜A 6.24
RPT (incl. resting muscle and skin) V˜rpt 19.81
Fat tissue V˜fat 12.78
Working muscle V˜mus 18.46
Liver V˜liv 1.73
Table B.1 – Physiological parameters and reference values: a Mo¨rk et al [77]
(according to the scaling for 70 kg body weight and 180 cm height), b Ottesen
et al [83] (according to table 8.2), c Filser [30].
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Parameter Workload
0 W 50 W 100 W 150 W
Tissue blood flow (% of cardiac output)
RPT (incl. resting muscle and skin) 0.545 0.34 0.25 0.22
Fat tissue 0.03 0.05 0.05 0.03
Working muscle 0.105 0.45 0.61 0.70
Liver 0.32 0.16 0.09 0.05
Table B.2 – Workload dependent fractional tissue blood flows according to
Mo¨rk et al [77].
B.2 Model Parameters
Parameter Symbol Nominal value (units)
Three Compartment
Parallel Lung Model
steady state and exercise blood flows qi = qi/Q˙c
(% of cardiac output)
compartment 1 0 (steady state), 0.3 (exercise)
compartment 2 0.2 (steady state), 0.3 (exercise)
compartment 3 0.8 (steady state), 0.4 (exercise)
steady state and exercise air flows vi = vi/V˙A
(% of alveolar ventilation)
compartment 1 0.8 (steady state), 0.4 (exercise)
compartment 2 0.2 (steady state), 0.3 (exercise)
compartment 3 0 (steady state), 0.3 (exercise)
compartment volumina V˜A,i
compartment 1 0.5 [l]
compartment 2 5 [l]
compartment 3 0.5 [l]
body compartment V˜body 12 [l]
production rate kpr 150 [nmol/min]
elimination rate kmet 2.4 [l/min]
body:blood partition coeff. λb:body 0.55
Table B.3 – Model parameters and nominal values
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Parameter Symbol Nominal value (units)
Stratified Lung Model
production rate kpr 133.2 [nmol/min]
metabolism rate kmet 1.86 [l/min]
proximal alveolar volume VA,1 3 [l]
distal alveolar volume VA,2 3 [l]
volume body V˜body 9 [l]
body:blood partition coeff. λbody:b 0.44
Table B.4 – Model parameters and nominal values
Appendix C
Symbols and Abbreviations
Primary symbols denoting physical quantities
C concentration nmol/l
P partial pressure mmHg
V compartment volume l
V˜ effective compartment volume l
V˙A alveolar ventilation l/min
Q˙c blood flow l/min
q fractional blood flow dimensionless
r ventilation-perfusion ratio
λb:air partition coefficient blood:air dimensionless
λb:x partition coefficient blood: compartment x dimensionless
kpr endogenous production rate nmol/min
kmet metabolic elimination rate l/min
Km Michaelis-Menten constant µmol/l
V xmax maximum metabolic rate in compartment x µmol/min
Secondary symbols denoting location of quantity
in gas phase in blood compartments
I inspired gas a arterial blood rpt richly perfused tissue
A alveolar gas c capillary fat fat compartment
E expired gas v venous blood mus muscle compartment
E¯ mixed expired gas v¯ mixed venous blood liv liver compartment
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